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background: Understanding the physiology of pregnancy enables effective management of pregnancy complications that could otherwise
be life threatening for both mother and fetus. A functional uterus (i) retains the fetus in utero during pregnancy without initiating stretch-induced
contractions and (ii) is able to dilate the cervix and contract the myometrium at term to deliver the fetus. The onset of labour is associated with
successful cervical remodelling and contraction ofmyometrium, arising from concomitant activation of uterine immune and endocrine systems. A
large body of evidence suggests that actions of local steroid hormones may drive changes occurring in the uterine microenvironment at term.
Although there have been a number of studies considering the potential role(s) played by progesterone and estrogen at the time of parturition,
the bio-availability and effects of androgens during pregnancy have received less scrutiny. The aim of this review is to highlight potential roles of
androgens in the biology of pregnancy and parturition.
methods: A review of published literature was performed to address (i) androgen concentrations, including biosynthesis and clearance, in
maternal and fetal compartments throughout gestation, (ii) associations of androgen concentrations with adverse pregnancy outcomes, (iii)
the role of androgens in the physiology of cervical remodelling and ﬁnally (iv) the role of androgens in the physiology of myometrial function
including any impact on contractility.
results: Some, but not all, androgens increase throughout gestation in maternal circulation. The effects of this increase are not fully under-
stood; however, evidence suggests that increased androgensmight regulate key processes during pregnancy and parturition. For example, andro-
gens are believed to be critical for cervical remodelling at term, in particular cervical ripening, via regulation of cervical collagen ﬁbril organization.
Additionally, a number of studies highlight potential roles for androgens in myometrial relaxation via non-genomic, AR-independent pathways
critical for the pregnancy reaching term. Understanding of the molecular events leading to myometrial relaxation is an important step towards
development of novel targeted tocolytic drugs.
conclusions: The increase in androgen levels throughout gestation is likely to be important for establishment and maintenance of preg-
nancy and initiation of parturition. Further investigation of the underlyingmechanisms of androgen action on cervical remodelling andmyometrial
& The Author 2014. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology.
This is anOpenAccess article distributed under the terms of the CreativeCommonsAttributionNon-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits
non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
Human Reproduction Update, Vol.0, No.0 pp. 1–18, 2014
doi:10.1093/humupd/dmu008
 Human Reproduction Update Advance Access published March 18, 2014
 at Edinburgh U
niversity on M
ay 19, 2014
http://hum
upd.oxfordjournals.org/
D
ow
nloaded from
 
contractility is needed. The insights gained may facilitate the development of new therapeutic approaches to manage pregnancy complications
such as preterm birth.
Key words: androgen / pregnancy / labour / cervix / myometrium
Introduction
Preterm birth (PTB), the outcome of preterm labour (PTL), is a major
cause of maternal and perinatal morbidity and mortality, occurring in
11% of recorded live births worldwide ranging from 5% in developed
countries to 18% in developing countries (Blencowe et al., 2012). The
exact cause of PTL is unknown, although the concomitant activation of
endocrine and immune pathways are believe to drive events, resulting
in spontaneous initiation of uterine contractions and cervical ripening
(CR) (Norman et al., 2007; Romero et al., 2007; Smith et al., 2012).
There is no fully effective agent for prevention of PTL. Progesterone
(P4) to maintain uterine quiescence, and cervical cerclage to prevent
premature CR have some efﬁcacy in terms of reducing PTB, but there
is little evidence of long-term beneﬁcial effects for the baby (Alﬁrevic
et al., 2012; Likis et al., 2012). Similarly, short term, but not long-term,
beneﬁts were demonstrated in a recent network analysis of tocolytics
(Haas et al., 2012). Thus, new strategies are needed.
Sex hormone steroids, including androgens, increase with normal
pregnancy. The role of androgens in female physiology has been an
active area of investigation for several decades. The major androgens
synthesized inwomenaredehydroepiandrosterone (DHEA), dehydroe-
piandrosterone sulphate (DHEAS), androstenedione (A4), testosterone
(T) and dihydrotestosterone (DHT) (Burger, 2002; Labrie et al., 2011;
Rothman et al., 2011) (Fig. 1). Although their impact on women’s
health has been investigated, particularly in the context of polycystic
ovarian disease, the role they play during pregnancy remains less well
described. A number of studies have explored androgenic actions in
systems critical for pregnancy reaching term, and further understanding
of their roles will facilitate management of potentially life-threatening
complications for the mother and the fetus.
Such key systems are cervical remodelling and myometrial contractil-
ity. In this reviewwediscuss (i) the biosynthesis, clearance and availability
of androgens during pregnancy, (ii) the associations of androgens with
adverse pregnancy outcomes, (iii) the role of androgens in physiology
of cervical remodelling and (iv) the roles of androgens in the physiology
of themyometrial function with a focus on the crosstalk between andro-
gens and myometrial contractile machinery.
Methods
Search strategy
We searched Pubmed using the keywords ‘androgens’ and ‘pregnancy’ to
conduct to our knowledge the ﬁrst narrative review decribing what is
known about androgens during pregnancy. The initial Pubmed search identi-
ﬁed 5976 manuscripts. Although the focus of this report was manuscripts
Figure 1 Testosteronemetabolism. DHEA, dehydroepiandrosterone; DHEAS, dehydroepiandrosterone sulphate, A4, androstenedione; T, testoster-
one; E1, estrone; E2, estradiol; E3, estriol; 3a-HSD, 3-a-hydroxysteroid dehydrogenase/D-5-4 isomerase; 3b-HSD, 3-b-hydroxysteroid dehydrogenase/
D-5-4 isomerase; 17b-HSD, 17b-hydroxysteroid dehydrogenase; 3a-Adiol, 5a-androstane-3a, 17b-diol; 3b-Adiol, 5a- androstane-3b,17b-diol; DHT,
dihydrotestosterone; STS, sulphatase; ST, sulfotransferase; 16a-OH, 16a-hydroxy.
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published between 1980 and 2013, seminal references from 1930 to 1980
were included. For a study to be included in this review, it had to focus on po-
tential roles for androgens in adverse pregnancy outcomes and processes
involved in parturition, such as cervical remodelling andmyometrial contract-
ility. In addition, studies on androgen metabolism and papers documenting
levels of androgens during pregnancy were included. Reports on the role
of androgens on fetal gonadal development, fetal lung development and
fetal immune systemwere not included. Following these inclusion and exclu-
sion criteria,500 studieswere judged as relevant andused to form thebasis
of this review.
Results
Androgen biology during pregnancy
Herein we introduce androgens in female physiology focusing on andro-
gen biosynthesis and androgen metabolic clearance at the time of preg-
nancy. Concentrations of androgens in the feto-maternal unit
throughout gestation are reviewed. Afterwards, we highlight studies cor-
relating androgen levels in the feto-maternal unit with adverse pregnancy
outcomes.
Androgens in female physiology
Androgens are critically important for the development of the male re-
productive tract during fetal life and the maintenance of male secondary
sexual characteristics in adulthood (Scott et al., 2007;Welsh et al., 2008;
Macleod et al., 2010). Androgens can also act as pro-hormones for bio-
synthesis of estrogens in both sexes (Rivas et al., 2002; Traish et al., 2011;
Purohit and Foster, 2012). In women, androgens are synthesized by cells
within the ovaries, the adrenal glands, and also in fat, acting in an endo-
crine, paracrine or intracrine manner. In addition to playing key roles in
the regulation of reproductive tissues such as the ovary and endomet-
rium, androgens have a functional impact on the liver, kidney, bone
and muscle (Brenner et al., 2003; Walters et al., 2008; Sen and
Hammes, 2010). An excess production of androgens in women, for
example in association with conditions such as polycystic ovarian syn-
drome (PCOS), can result in acne, hirsutism and infertility as well as to
an increase in the risk of other complications, such as high blood pres-
sure, cardiovascular disease and type 2 diabetes mellitus (Rosmond,
2006; Dewailly, 2010; Escobar-Morreale et al., 2012). Since the 1960s,
it has been generally hypothesized that, during pregnancy, androgens
act as substrates for estrogen formation in the placenta (Pion et al.,
1965; Siiteri and MacDonald, 1966; Edman et al., 1981; Smith, 2007).
According to this hypothesis, DHEAS, produced by the fetal adrenals,
and to a smaller extent from the maternal adrenals, enters the placenta,
where it is metabolized to A4 and T, which is then converted into E1
(estrone) (Strauss et al., 1996). E1 is in turn converted into E2 (estradiol),
which enters the fetal circulationwhere it is takenupby the liver and con-
verted into E3 (estriol) (Hirano, 1961; Schwarzel et al., 1973). E3 can
then pass to maternal circulation and be cleared in maternal urine
(Willows, 1966). Androgen biosynthesis during pregnancy is extensively
discussed later in this review and shown in Fig. 1.
Androgen-dependent signalling
The importanceof theandrogen receptor (AR) inmediating theeffectsof
androgens is well documented. For example, mutations or deletions in
the AR gene located on the X chromosome are associated in both man
and mouse with failure to masculinize. This results in ‘testicular
feminization’, a conditionwhere amalewith a 46XY karyotype is pheno-
typically female (Lubahn et al., 1988; Charest et al., 1991; Hughes et al.,
2012). TheAR is amemberof a superfamily of ligand-activated transcrip-
tion factors; only T and DHT bind AR with high speciﬁcity and afﬁnity
(Pereira de Jesus-Tran et al., 2006). Ligand binding within the cytoplasm,
where the classicAR resides, results in a conformational change in recep-
tor protein, dimerization, nuclear translocation, association with
co-factors and ultimately interaction with speciﬁc regions of the
genome known as androgen response elements (Denayer et al., 2010).
The net result of these changes is an up- or down-regulation in gene ex-
pression. Such a response is termed ‘genomic’ as it involves gene tran-
scription. In addition to their genomic effects, androgens are also able
to exert their effects in a ‘non-genomic’ manner, independent of gene
transcription or protein synthesis (Lang et al., 2013). Non-genomic
effects of androgens involve interaction with the cell membrane via a
numberof signallingmolecules, includingmembrane receptors, ion chan-
nels or enzyme-linked receptors and cytoplasmic regulatory proteins
(Foradori et al., 2008). These non-genomic effects are rapid and can
be observed within seconds, in contrast to genomic effects, which may
take hours or even days.
Androgen biosynthesis
The biosynthetic conversion of cholesterol (Ch) to androgens involves
several steps and enzymes. A fundamental step in this process is the syn-
thesis of pregnenolone. Only certain cell types in humans are capable of
pregnenolone manufacture, including testicular Leydig cells, ovarian
theca and corpus luteum cells, placental trophoblast cells, adrenal
cortex cells and some speciﬁc cells in the brain (reviewed in Ghayee
and Auchus, 2007). Pregnenolone is metabolized to DHEA, which is
further metabolized to A4, the precursor of T. T can be reduced to a
number of androgens, such as 5a-DHT (DHT), 5b-DHT, 5b-
androstandiol, 3a-Adiol, 3b-Adiol or further metabolized to estrogens.
The reduction of T to DHT and the conversion of T to estrogens is cat-
alysed by the metabolising enzymes 5a-reductase and aromatase
(CYP19), respectively (Fig. 1). Androgen biosynthesis has been exten-
sively reviewed by Penning (2010).
In the non-pregnant premenopausal woman, 50% of all DHEA is
secreted by the adrenal glands, 20% from the ovaries and 30% from
the peripheral tissues (Abraham, 1974). In contrast, the adrenals and
ovaries produce equal amounts of A4 (Longcope, 1986). Regarding T,
50% is equally synthesized in the ovaries and adrenals and the other
half is produced from A4 in the peripheral tissues (Piltonen et al.,
2002). Finally, DHT is not secreted by the endocrine glands, and this an-
drogen is synthesized from T in the peripheral androgen target tissues
(Ito and Horton, 1971; Marchetti and Barth, 2013). During pregnancy,
an additional sourceof androgens is the fetus and theplacenta. In particu-
lar, the developing fetus is the source of placental 16a-hydroxy-DHEA, a
product of 16a-hydroxylation of DHEAS in the fetal liver (Cantineau
et al., 1985). In a similar way to its non-16a-hydroxylated form,
16a-hydroxy-DHEA can be metabolized to 16a-hydroxy-A4. The
latter is the predominant source of E3 (Milewich et al., 1986) (Fig. 1).
Once synthesized, androgens enter the maternal circulation, where
their levels can be detected. Usually T levels are reported as either
total (tT) or ‘free’ (fT) with an important distinction between them;
the latter are unbound to plasma proteins, such as sex-hormone-binding
globulin (SHBG), and therefore able to pass freely across plasma mem-
branes to interact with AR, whereas bound T is unable to penetrate
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the cell membrane (Mendel, 1989). The percentage binding of SHBG is
greater for DHT (59%) than for T (44%) and E2 (20%) and is very low for
A4, DHEA, E1 and E3 (Avvakumov et al., 2010). The afﬁnity of each
androgen for SHBG is dependent on their structural characteristics.
For example, a 17b-OH group and a 5a-hydrogen moeity increase the
afﬁnity for SHBG binding, whereas androgens with either a double
bond in ring A or an aromatic ring A are less SHBG potent (Siiteri and
Simberg, 1986). Therefore, DHT, which has both the 17b-OH group
and a 5a-hydrogen atom, has 2-fold greater afﬁnity for SHBG than T,
which has a double bond in ring A (Siiteri and Simberg, 1986).
Concentrations of androgens during pregnancy
A number of studies have reported elevated levels of some, but not all,
circulating androgens during normal pregnancy (Mizuno et al., 1968;
Rivarola et al., 1968; Saez et al., 1972; Dawood and Saxena, 1977;
Buster et al., 1979; Bammann et al., 1980).
A notable increase in tT is observed from the ﬁrst trimester of preg-
nancy and further elevations are reported towards term (Saez et al.,
1972; Bammann et al., 1980; Berger et al., 1984). However, circulating
fT levels only increase signiﬁcantly at the third trimester of pregnancy
(Dawood and Saxena, 1977). In addition, serum A4 is signiﬁcantly ele-
vatedbetween37–42weeksof pregnancy comparedwith non-pregnant
levels, but the relative increase of T during pregnancy is greater than the
increase in A4 (Mizuno et al., 1968). In contrast, maternal circulating
DHEAS levels fall across gestation to 50% of the non-pregnant levels
(Milewich et al., 1978). Finally, SHBG levels increase during the ﬁrst tri-
mester of pregnancy and continue to increase dramatically throughout
mid and late gestation (Wilke and Utley, 1987). Table I summarizes
the maternal serum levels of different androgens during pregnancy and
Fig. 2 is a graphical representation of this information.
In the fetus, levels of some androgens are dependent on fetal sex and
gestation. In fetal blood, T levels are higher inmales (Rodecket al., 1985).
This contrasts with DHT levels, which are similar in both sexes (Diez
d’Aux and Pearson Murphy, 1974; Rodeck et al., 1985). In male
fetuses, serum concentrations of T increase until the end of ﬁrst trimes-
ter, reaching apeakof 150 ng/dLat theendofweek12of gestation, after
which they decline by 70% to a nadir at 23weeks (Rodeck et al., 1985). In
female fetuses, T levels remain generally lower throughout ﬁrst and
.............................................................................................................................................................................................
Table I Levels of androgens in maternal serum.
Androgen Non-pregnant First trimester Second trimester Third trimester References
fT (pmol/l) 6.2 11.1 7.5 13.3 Wilke and Utley (1987)
tT (mmol/l) 0.21–2.98 0.90–7.32 1.20–8.40 2.20–10.70 O’Leary et al. (1991)
A4 (ng/ml) 1.0–2.0 2.5–3.5 0.6–7.8 1.6–14.0 Castracane et al. (1998), Carlsen et al. (2006)
DHT (ng/ml) 0.022–0.107 0.113 0.18 0.1–0.3 Buster et al. (1979), Dawood and Saxena (1977)
SHBG (nmol/l) 42.2 68.1 279.3 246.1 Wilke and Utley (1987)
DHEA (nmol/l) 1.0–40.0 10.0–60.0 5.0–50.0 5.0–50.1 Tagawa et al. (2004)
DHEAS (nmol/l) 2000–4000 2000–4000 500–2000 500–200 Tagawa et al. (2004)
The table shows the mean concentrations of androgens as given in references quoted. tT, total testosterone; fT, free testosterone; SHBG, sex hormone binding globulin; DHEA,
dehydroepiandrosterone; DHEAS, dehydroepiandrosterone sulphate; A4, androstenedione; DHT, dihydrotestosterone.
Figure2 Graphical presentation of the highest (A) and lowest (B) levels of androgens inmaternal serum throughout gestation. tT, total testosterone; fT,
free testosterone; SHBG, sex hormone-binding globulin; DHEA, dehydroepiandrosterone; DHEAS, dehydroepiandrosterone sulphate; A4, androstene-
dione; DHT, dihydrotestosterone.
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second trimester (50 ng/dL) and decline rapidly at term (Diez d’Aux and
PearsonMurphy, 1974). In addition to T, DHEA levels are higher in cord
blood of male fetuses compared with females, whereas A4 levels are
similar (Keelan et al., 2012). Labour is associated with increased levels
of cord blood A4, DHEA and SHGB and decreased levels of tT and fT
(Keelan et al., 2012). In amniotic ﬂuid, T and A4 are higher in male-
bearing pregnancies (Carson et al., 1982). On the other hand, there is
no notable difference in amniotic ﬂuid DHEA levels between male and
female fetuses (Robinson et al., 1977). Although T levels are higher in
the fetal compartment of male fetuses, there is no association
between fetal sex and maternal serum concentrations of any androgen
(Rivarola et al., 1968). The association between fetal sex and androgen
levels, T or A4, in the fetal compartment, including serum and amniotic
ﬂuid, is consistent with androgen biosynthesis within Leydig cells of the
fetal testis (Scott et al., 2009). Therefore, increased T and A4 levels in
the amniotic ﬂuid of male fetuses may reﬂect androgens excreted in
fetal urine (Mitchell and Shackleton, 1969). The tissue origin and cause
of the increase in androgens in maternal circulation during pregnancy
remains uncertain but is likely to involve production from the ovary or
placenta as discussed below.
Tissue origin of androgen synthesis during pregnancy
Within the ovary, androgens are synthesized in small luteal cells (SLC) of
the corpus luteum (former theca cells of ovarian follicle) (Sanders et al.,
1996). Once pregnancy occurs, it is plausible that SLC stimulation by
human chorionic gonadotrophin (hCG), which is elevated in ﬁrst trimes-
ter, results in the reported increase in T levels at this time (Braunstein
et al., 1976; Liu and Hsueh, 1986). However, hCG levels reach a peak
at the end of ﬁrst trimester and then decline, in contrast to T, which
increases steadily, suggesting either an alternative regulation of androgen
production by the corpus luteum or an alternative source of androgen
increase following the end of the ﬁrst trimester (Braunstein et al.,
1976). Studies on women with premature ovarian failure (POF) who
become pregnant following in vitro fertilization (IVF) with donor oocyte
transfers suggest that the ovary is the major contributor to circulating
concentrations of T and A4 during pregnancy (Castracane and Asch,
1995). Such women were shown to have signiﬁcantly lower levels of T
and A4 when compared with pregnant women without POF. Perhaps
not surprisingly, such studies are yet to be replicated by other research
groups.
In addition to thematernal ovary, thematernal adrenal is an important
source of androgen production throughout pregnancy. Indeed maternal
and fetal virilization due to androgen excess have been reported in cases
of adrenal adenomas (Fuller et al., 1983). Studies in baboons showed that
the maternal adrenal production of DHEA and DHEAS is suppressed
during pregnancy by E2; this is in line with a reported decrease in
DHEAS in maternal circulation throughout pregnancy (Albrecht and
Pepe, 1995; Umezaki et al., 2001; Tagawa et al., 2004). These studies
demonstrated that removal of the fetus but not theplacenta (fetectomy),
in order to eliminate a fetal source of DHEA/DHEAS, induced a decline
in E2 and an increase in DHEA/DHEAS levels in thematernal circulation
(Albrecht et al., 1980; Albrecht and Pepe, 1995). The decrease in E2 is
probably due towithdrawal of fetal precursors for E2 formation. Interest-
ingly, the authors showed that exogenous E2 could inhibit the
fetectomy-induced increase in DHEA/DHEAS. The observation that
metabolic clearance rate of DHEA/DHEAS remained unchanged
before and after E2 administration, led authors to conclude that the
estrogen-induced decline in maternal DHEA/DHEAS levels reﬂected a
decrease in maternal adrenal production of these androgens.
Despite the prevailing belief from studies from1960s that the placenta
does not hold the metabolic capacity to synthesize androgens de novo,
but relies solely on fetal androgens, a recent study has demonstrated that
placental syncytiotrophoblast (but not cytotrophoblast) can synthesize
androgens (Pion et al., 1965; Siiteri and MacDonald, 1966; Escobar
et al., 2011). Speciﬁcally, syncytiotrophoblast expresses both mRNA
and protein of the metabolising enzyme CYP17, which converts C21
steroids (such as P4) to C19 steroids (such as T). The syncytiotropho-
blast has been conﬁrmed to have CYP17 activity in vitro (Escobar et al.,
2011).
The non-pregnant human myometrium has been shown to possess
the metabolic capacity to convert A4 to T and DHT in vitro, but
whether this system is functional in pregnancy is unknown (Jasonni
et al., 1982). Consistent with this, a more recent study has reported
that myometrium, derived from non-pregnant and early pregnant pig
uteri, can synthesize A4 and T in vitro (Franczak, 2008). Whether the
cervix during pregnancy has the metabolic capacity to synthesize andro-
gens is unknown.
Figure 3 summarizes possible sites for androgen production in the
materno-placental unit.
Androgen clearance during pregnancy
The concentrations of androgensmeasurable in blood (Pc) are also inﬂu-
enced by their metabolic clearance rate (MCR), the volume of blood
cleared of a steroid per unit time (Baird et al., 1969). The blood produc-
tion rate of an androgen (Pb) is the amount of androgen entering circu-
lation from all possible sources (endocrine glands and periphery). This
can be calculated according to the formula Pb ¼ MCR x Pc and it repre-
sents an approximation of daily production rate of the steroid (Gurpide,
1990). TheMCRof androgens, which represents the summation of indi-
vidual organ clearance rates, is highly inﬂuenced by the amounts of circu-
lating SHBG, which reduces the peripheral breakdown of androgens
(Vermeulen and Ando, 1979).
Soon after implantation, the production ofmaternal P4, E2 and andro-
gens by the corpus luteum increases signiﬁcantly (Elbaum and Keyes,
1976; Stouffer et al., 1977; Richardson and Masson, 1981; Laherty
et al., 1985; Webley and Hearn, 1987; Fisch et al., 1989; Brannian and
Stouffer, 1991; Stocco et al., 2007). Corpus luteum-derived E2 stimu-
lates liver SHBG synthesis leading to an increase in SHBG levels (Wilke
and Utley, 1987; Joseph, 1994). The increase in SHBG should decrease
the availability of fT and therefore lower the clearance of T and DHT.
Indeed, it has been reported that the MCR of T and DHT is lower
during the ﬁrst three months of pregnancy compared with the non-
pregnant state; however, DHT and T blood production rates are un-
changed (Saez et al., 1972). These ﬁnding are in agreement with a
study in guinea-pigs, where pregnancy induced a 2-fold decrease in
MCR of T (Despres et al., 1982).
In contrast to T and DHT, the MCR of DHEA and DHEAS increases
2- and 5-fold, respectively, starting at mid-pregnancy (Gant et al.,
1971; Belisle et al., 1977; Belisle et al., 1980b). This phenomenon may
reﬂect the metabolism of these steroids in the feto-placental unit, as
both steroids are important as estrogen precursors (Goodyer and Bran-
chaud, 1981; Longcope, 1996). In addition to the increase in theMCRof
DHEAS, its production rate bymaternal adrenals increases in pregnancy
(Milewich et al., 1978). The net result is lower DHEAS levels in the
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maternal serum at the end of ﬁrst trimester in comparison with the non-
pregnant state (Tagawa et al., 2004). For A4, although pregnancy does
not induce changes in the MCR, the production rate is increased
2-fold, explaining the observed increase in A4 in the blood (Belisle
et al., 1980a, b; Castracane et al., 1998).
In conclusion from the above studies, it is understood that changes in
the production of androgens (predominantly in the ovary and to a lesser
extent in the adrenals and periphery) and the MCR occurring during
pregnancy may all have an impact on androgen concentrations in the cir-
culation.Of note, changes in concentrationsof circulating androgensmay
not reﬂect the bioavailability of these steroids in target tissues and there-
fore their potential to play a role in the physiology of tissues such as the
myometrium, cervix and placenta. The role of the increase in androgen
levels during pregnancy has been understudied, although a number of
adversepregnancyoutcomeshavebeencorrelatedwith impairedmater-
nal androgen levels. These studies are discussed below.
Androgens and adverse pregnancy outcomes
Considering the adverse effects of increased circulating androgens in
non-pregnant women, such as in PCOS, one would assume that the
physiological pregnancy-induced increase in androgen levels could po-
tentially have similar detrimental effects. However, it is generally
accepted that pregnancy-speciﬁc mechanisms are activated to protect
both the mother and fetus from pregnancy-induced androgen excess
(Hensleigh et al., 1975). In the absenceof these ‘protective’mechanisms,
high levels of androgenswould cause hirsutism and/or virilizationof both
mother and female fetus.
Maternal ‘protective’ mechanisms include (i) the physiological in-
crease of maternal circulating SHBG, which binds and inactivates ele-
vated androgens (Hammond, 2011) (ii) the pregnancy-induced rapid
elevation of P4, which competes for AR binding (Slayden et al., 2001;
Birrell et al., 2007) and (iii) P4 having an afﬁnity for 5a-reductase resulting
in an inhibition of the conversion of T to themorepotentDHT (Hodgins,
1982; Cabeza et al., 1999). Due to these mechanisms, pregnancy itself
may reduce the clinical manifestation of pre-existing or pathological
pregnancy-induced hyperandrogenic conditions (Phelan and Conway,
2011; Crisosto et al., 2012). Themost common hyperandrogenic condi-
tions are known as ‘non-tumour ovarian hyperandrogenism’ and include
PCOS, hyperreactio luteinalis (HL) and pregnancy luteoma (Kanova and
Bicikova, 2011).Numerous cases of HL, occurring predominantly during
the second or third trimester and caused by high b-human chorionic go-
nadotrophin (b-hCG) levels, have been reported (Haimov-Kochman
et al., 2004; Van Holsbeke et al., 2009; Amoah et al., 2011). These
studies highlight that, in spite of the protective mechanisms, a small frac-
tion of women with HL exhibit virilization and/or hirsutism, although
their female fetuses are hardly ever virilized (Hensleigh et al., 1975;
Foulk et al., 1997; Holt et al., 2005; Angioni et al., 2007; Van Holsbeke
et al., 2009; Veleminsky, 2010; Abe et al., 2011; Amoah et al., 2011;
Annamalai et al., 2011). Although most maternal hyperandrogenic
symptoms of HL resolve post-partum, HL is highly associated with
adverse pregnancy outcomes such as pre-eclampsia (PE) and PTB
(Gatongi et al., 2006; Grgic et al., 2008; Masuyama et al., 2009; Atis
et al., 2010; Haq, 2010; Simsek et al., 2012; Lynn et al., 2013). Other
hyperandrogenic disorders, which are generally very rare, include
fetal-induced hyperandrogenism, due to fetal aromatase deﬁciency
Figure 3 Maternal sites of androgen synthesis. The maternal adrenal gland secretes DHEA, DHEAS, A4 and T to the maternal circulation, from which
androgens getdistributed toperipheral tissues. Placenta is an additional site fordenovo synthesisofA4andTsynthesis.Ovaries can alsoproduce and secrete
T, A4 and DHEA into maternal circulation. Myometrium can also synthesize A4, T and DHT. Finally, DHEA and T can be generated from precursors by
androgen metabolizing enzymes. DHEA, dehydroepiandrosterone; T, testosterone; DHT, dihydrotestosterone; DHEAS, dehydroepiandrosterone
sulphate; A4, androstenedione.
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(FAD), iatrogenic hyperandrogenism, caused by exogenous androgen
administration and adrenal tumour hyperandrogenism (Dahl et al.,
2008).
Fetal ‘protective’ mechanisms largely include the metabolism of
androgens in the placenta (Siiteri and MacDonald, 1966; Simpson
et al., 1994). Speciﬁcally, the aromatase complex within the placenta
plays a critical role in theprotectionof fetus fromthemother’s androgens
as this enzyme rapidly converts T or A4 to E1 and E2, respectively
(Edman et al., 1981; Bardin et al., 1983; Hall et al., 1987; Pasanen and
Pelkonen, 1994; Simpson et al., 1994). The efﬁcacy of this placental
barrier to androgens is evidenced by studies showing that women with
hyperandrogenic disorders during pregnancy, such as PCOS, do not ne-
cessarily deliver virilized female fetuses (Sir-Petermann et al., 2002;
Escobar-Morreale, 2010). On the other hand, women with rare FAD
can deliver virilized fetuses, again demonstrating the crucial importance
of placental aromatase (Shozu et al., 1991; Ludwig et al., 1998). Taken
together, these studies showthatpregnancy is associatedwithprotective
mechanisms, which ameliorate both maternal and fetal effects of the an-
drogen increase associated with normal pregnancy physiology.
Besides the physiological androgen increase, numerous studies have
explored the association of impaired androgen increases during preg-
nancy, and factors such as maternal age and sex of the baby, with preg-
nancy outcome. Women with PCOS, who have higher androgen levels
than healthy pregnant women, are reported to have an 6% higher
risk of delivering preterm than women without PCOS (Sir-Petermann
et al., 2005; Yamamoto et al., 2012). However, androgen excess might
not be the only reason for early birth in these women, as PCOS is also
associated with an increase in many inﬂammatory mediators, which
may contribute to PTL (Diamanti-Kandarakis et al., 2006). A study inves-
tigating the association of birth size of the offspring with maternal andro-
gens has shown that elevated T is positively associated with in utero
growth restriction (Carlsen et al., 2006). In addition, women pregnant
with male fetuses are at greater risk of delivering preterm (McGregor
et al., 1992; Zeitlin et al., 2002), a phenomenon sometimes attributed
to the fact that pregnancieswithmale fetuses have higher levels of andro-
gens in the fetal compartment compared with female fetuses. However,
there is no evidence that the relationship betweenhigher androgen levels
in the fetal compartment and PTB is causal. In contrast to the positive as-
sociation between androgen levels (at least in the fetal compartment)
and the presence of a male fetus and PTB, increasing maternal age
(which is negatively associated with maternal androgen levels in preg-
nancy) is known to be a risk factor for preterm deliveries (Astolﬁ and
Zonta, 1999; Carlsen et al., 2003). Recently, a speciﬁc change in the se-
quence of the fetal AR gene has been associated with predisposition to
PTB (Karjalainen et al., 2012). In particular, a linkage analysis study
revealed that the exon-1 of AR of the offspring who was born preterm
had more repetitions of a sequence encoding for a site in the domain
involved in ligand activation (Karjalainen et al., 2012). Abnormal increase
in androgens during pregnancy has been additionally correlated with the
development of gestational diabetes, which is further associated with
PTB (Espinos et al., 1992; Abbott et al., 2010; Vejrazkova et al., 2014;
Ackerman et al., 2013; Morisset et al., 2013). This is probably due to
the role of androgens in modulation of insulin secretion from the pan-
creas and inhibition of glucose uptake in fat and muscle cells (Corbould,
2008; Rao et al., 2013). Themechanism linking the two hormonal axes is
poorly understood and, interestingly, has not been considered or
explored during pregnancy. Increased T levels in thematernal circulation
at third trimester have been associatedwith the incidence of PE, suggest-
ing T as a predictive marker (Ghorashi and Sheikhvatan, 2008; Lorzadeh
andKazemirad, 2012; Sharifzadeh et al., 2012; Simsek et al., 2012). In this
context, placentae from preeclamptic pregnancies have higher expres-
sion levels of AR in both male and female fetuses (Sathishkumar et al.,
2012). Therefore, it is possible that AR signalling in the placenta contri-
butes to the pathology of PE.
The association of androgen levels with preterm delivery has been
studied in a fewprimate studies. For example, continuous administration
of A4 to pregnant rhesusmonkeys fromearly gestation or for a period of
48 h during third trimester resulted in preterm initiation of myometrial
contractions and cervical dilatation leading to pretermdelivery (Figueroa
et al., 1989; Mecenas et al., 1996). In these studies, preterm delivery was
associated with an increase in E2 in maternal circulation, suggesting con-
version of A4 to E2 in the placenta. Nathanielsz et al. (1998) later sup-
ported that notion by showing that the preterm phenotype could be
rescued by administration of an aromatase inhibitor. However, in
other studies, direct administration of E2 or E1 to pregnant primates
failed to induce preterm delivery (Novy and Walsh, 1983; Albrecht
et al., 1989). Therefore, it is likely that a physiological increase in andro-
gen levels inmaternal circulation from the start to endof pregnancy holds
the key to termpregnancy. In support of this notion, abnormal changes in
androgens levels at the start of pregnancy have been associated with
spontaneous abortions or recurrent miscarriages. For example, spon-
taneous abortion was shown to occur in women whose androgen
levels failed to increase at the beginning of pregnancy (Bammann et al.,
1980). On the other hand, women with recurrent miscarriages had sig-
niﬁcantly higher levelsofT,A4andT/SHBGratiocomparedwithwomen
without recurrent miscarriages (Okon et al., 1998).
Although these studies emphasize how the normal increase in andro-
gen levels might be pivotal for maintenance of pregnancy and develop-
ment of the fetus, they fail to show a consistent relationship between
either androgen excess or androgen deﬁciency and pregnancy problems.
What is more, the mechanism by which androgens impact pregnancy
outcomes has not been fully understood. Below we discuss the effect
of androgens on cervical remodelling and myometrial function, the key
processes in determining the timing of delivery. Particular focus is paid
to myometrial smooth muscle cell (MSMC) physiology and the ability
of androgens to interact with the contractile machinery of the cell.
The role of androgens in CR
Structure of cervix during pregnancy
The cervical stroma is composed of ﬁbroblasts, smooth muscle cells
(SMCs), epithelial cells and immune cells (Leppert, 1995). These cells
secrete an extracellular matrix (ECM), which consists primarily of colla-
gen, glycosaminoglycans and proteoglycans. Hormones including pro-
gestogens and E2, relaxin and prostaglandin can alter ECM
composition and affect the mechanical strength of the cervix
(Ekman-Ordeberg et al., 2003; Simon and Einspanier, 2009; Ji et al.,
2011;Ghule et al., 2012). The consequenceof this process is remodelling
of the cervix,which canbedivided into four stages: softening (ﬁrst trimes-
ter), ripening (second trimester), dilatation (third trimester) and recon-
stitution of the non-pregnant cervix post-partum (Read et al., 2007).
Each stage has a characteristic collagen and proteoglycan composition
as the tissue re-organizes and prepares for the next steps in the partur-
ition process (Word et al., 2007). CR is characterized by a 60% decrease
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in collagen and proteoglycan levels and occurs in parallel with an increase
in collagenase activity, which itself is involved in collagen catabolism and
disturbance of collagen bundles (Ekman et al., 1986; Norman et al.,
1993). However, collagen synthesis increases in the cervix at term due
to collagen turnover being balanced between production and degrad-
ation (Ekman et al., 1986). Structural abnormalities of the cervix have
been associated with an increased risk of PTB, thus a better understand-
ing of the physiology of cervical remodelling is crucial (reviewed by
Norman, 2007).
The role of androgens in CR
Numerous human and animal studies have explored the role of andro-
gens in the cervix, particularly during pregnancy (Mochizuki et al.,
1978a, b; Sasaki et al., 1982; Mochizuki and Maruo, 1985; Takahashi
et al., 1984; Sakyo et al., 1986, 1987; Yamashita et al., 1991; El
Maradny et al., 1996; Kanayama et al., 1998; Ji et al., 2008). These
studies formed the basis of a hypothesis, whereby androgens regulate
cervical remodelling, particularly CR at term. Table II summarizes key
ﬁndings from these studies. Collectively, these reports provide enough
evidence that the fetal androgen, DHEAS, promotes CR by enhancing
collagenase activity and thus decreasing ﬁbril collagen organization.
Mechanism of androgen effect on CR
The physiology or pharmacology of androgen effects on CR is not fully
understood. In support of a physiological effect of DHEAS on CR, one
study has reported thatDHEAS levels are signiﬁcantly correlatedwith fa-
vourable outcome according to the Bishop score, i.e. higher levels of
DHEAS in women with successful (spontaneous) CR compared with
women in needof induction of labour (Koyuncu et al., 1995).DHEAS ad-
ministration has been additionally positively correlated with increases in
E2 levels in maternal serum (Takahashi et al., 1984). Therefore, it has
been argued that DHEAS is metabolized to estrogens in term cervix,
which in turn initiates CR. However, studies examining such effects
showed that administration of estrogens alone fails to ripen the cervix
(Thiery et al., 1979; Larmon et al., 2002; Dasgupta and Singh, 2012).
Notably DHT, which cannot be metabolized to estrogens, also pro-
motes CR, implying an androgen-speciﬁc effect (Ji et al., 2008). Interest-
ingly, mice with knockout (KO) of 5a-reductase type 1 develop an
abnormal cervix that fails to ripen at labour (Mahendroo et al., 1999).
5a-reductase type 1 converts T to DHT and is the predominant
enzyme expressed in cervix at term (Mahendroo and Russell, 1999).
Administration of a 5a-reduced androgen, a metabolite of DHT,
5alpha-androstane-3alpha, 17b-diol, rescues the impaired phenotype
of 5a-reductase type 1 KO animals, allowing normal CR (Mahendroo
et al., 1996). The latter ﬁnding suggests local conversion of androgens
to other (more potent) androgenmetabolites as the underlyingmechan-
ism in the initiation of CR.
Although poorly explored, there is some evidence to suggest that the
mechanismofDHEASactionon the collagenase increase is indirect and is
mediated via DHEAS-stimulated neutrophil secretion of the proteolytic
enzyme (El Maradny et al., 1996; Maymon et al., 2000). Indeed, DHEAS
action on CR has been correlated with increased levels of IL-8 cytokine
involved in chemotaxis of neutrophils recruited in cervix towards term
(Kanayama et al., 1998; Maymon et al., 2000).
The involvement of AR in mediation of CR by androgens has been re-
cently examined (Ji et al., 2008). In that study, antagonism of AR by
ﬂutamide inhibited events associated with CR, such as a decrease in col-
lagen ﬁbril organization, a decrease in cervical resistance and a decrease
in proteoglycan synthesis in pregnant rats pre-treated with DHTon Day
16, suggesting genomic signalling (Ji et al., 2008). Although this study did
not examine AR expression in the cervix, other immunohistochemical
studies in non-pregnant and pregnant humans and canine cervix have
demonstrated cervical expression of AR (Wilson and McPhaul, 1996;
Vermeirsch et al., 2002; Ji et al., 2008; Vladic-Stjernholm et al., 2009).
In addition, it has been reported that androgens up-regulate AR expres-
sion in the human cervix (van der Kwast et al., 1994).
All the above reports suggest thatDHEAandDHTmight promoteCR
via a pathway impacting collagenase synthesis and/or activity. Although
the mechanism of this action is not well established, there is some evi-
dence that it is possibly mediated via metabolism of androgens to
reduced androgens and/or genomic signalling through AR. This notion
needs more investigation. In addition, the role of androgens and andro-
gen signalling in the cervical endothelial/epithelial cells and cervical SMCs
in terms of cervical remodelling throughout pregnancy is surprisingly
unexplored.
The role of androgens in myometrial function
MSMCs changes during pregnancy
MSMCs are specialized contractile cells that, in contrast to skeletal and
SMCs, exhibit cellular plasticity, which enables reversible differentiation
into different phenotypes (Gabbiani et al., 1981; Tomiyasu et al., 1988).
Studies of myometrium during rat pregnancy have demonstrated that
MSMCs undergo four phenotypic changes throughout gestation (Shyn-
lova et al., 2009). Brieﬂy, these are a proliferative stage, a synthetic
stage, a contractile stage and, ﬁnally, a labour stage. In early pregnancy,
following implantation of the conceptus, MSMCs proliferate rapidly
and become hyperplastic. Hyperplasia is believed to be mediated by
hormone signalling and growth factors, such as IGF-1 and EGF, have
been shown to be involved in induction of the so-called proliferative
phenotype (Shynlova et al., 2007). Following the proliferative phase,
MSMCs undergo an intermediate synthetic phase starting on Day 14 of
rodent pregnancy (Lye et al., 2001). The synthetic phenotype is charac-
terized by increased synthesis of ECM and cellular hypertrophy of
MSMCs (Shynlova et al., 2009). On Day 21 of rodent gestation, uterine
myocytes switch to a contractile phenotype (Nishinaka and Fukuda,
1991; Fata et al., 2000; Shynlova et al., 2004). Differentiation into a con-
tractile phenotype is largely attributed to mechanical stretch (Manabe
et al., 1981; Loudon et al., 2004; Sooranna et al., 2004; Terzidou et al.,
2005).MSMCs undergo a ﬁnal phase of differentiation following initiation
of labour, the so-called labour phenotype (Shynlova et al., 2009). At this
point, the myometrium develops synchronous contractions and
expresses a number of contraction-associated proteins (CAPs), such
as connexin 43 (Con43), oxytocin receptor (OXTR) and prostaglandin
F receptor (Fuchs et al., 1984; Slateret al., 1999; Spareyet al., 1999; Erkin-
heimo et al., 2000; Rehman et al., 2003). Returning MSMCs to a non-
pregnant state involves rapid apoptosis (Roh et al., 2000; O’Brien
et al., 2007; Shynlova et al., 2009).
A recent study, conducted in rats, reported thatAR is highly expressed
in MSCMs during the proliferative stage and progressively declines
towards the end of pregnancy, suggesting a role (at least in this
species) in establishment of myometrial growth at early stages of preg-
nancy (Liu et al., 2013). Liu et al. additionally showed that the AR
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decrease itself affects IGF-1 receptor (IGF-1R) stability and thus down-
regulates downstream cascades that IGF-1 is involved in (including
P13K/Akt, which is highly important in proliferative pathways) (Liu
et al., 2013). Besides rats, a signiﬁcant decrease in AR expression
occurs in porcine myometrium 3 weeks prior to labour (Slomczynska
et al., 2008). A human microarray study also showed AR gene down-
regulation in the myometrium during preterm (0.4-fold) and term
labour (0.3-fold) compared with non-labouring myometrium, but the
proteinexpressionwasnotdetermined (Bethinet al., 2003).Thus, andro-
gen signalling in MSMCs is likely to be involved in proliferative pathways
pivotal for ‘building’ of the myometrium in the early stages of pregnancy.
The role of androgens in myometrial contractility
Androgens have been demonstrated to relax SMCs, such as rabbit and
pig trachea, rat mesenteric arterial bed, rat thoracic aorta and human
coronary artery (Perusquia et al., 1991a, b; Chou et al., 1996; Costarella
et al., 1996;Rosano et al., 1999;Tep-areenan et al., 2002; Perusquia et al.,
2005; Kouloumenta et al., 2006; Bordallo et al., 2008; Montano et al.,
2008; Chevalier et al., 2012). Robson (1937) was the ﬁrst to suggest
that androgens may have an inhibitory action on uterinemuscle contrac-
tion. Following a 4-day administration of 12 mg of testosterone propion-
ate (a small fast-acting ester of testosterone) to ovariectomized
non-pregnant rabbits, he examined the contractile response of their
.............................................................................................................................................................................................
Table II Studies on the effect of androgen administration on CR.
Androgen Dose Species/tissue Key ﬁndings Reference
DHEAS 0.01 mg/ml
0.1 mg/ml
Human
In vitro: HCF derived from term pregnancy
 IL-8 in conditioned medium
 IL receptor in HCF
Kanayama et al.
(1998)
DHEAS 200 mg Human
In vivo: term pregnant women (.38 weeks)
 Bishop score
 Collagenase activity
Mochizuki et al.
1978a, b
DHEAS 200 mg Human
In vivo: term pregnant women (38–42 weeks)
 Bishop score
 Collagenase activity
 E2 in maternal serum
Mochizuki and Maruo
(1985)
DHEAS 50–100 mg Human
In vivo: term pregnant women (38–42 weeks)
 Bishop score
 Time to delivery
No side effects
Mochizuki et al.
1978a, b
DHEAS 100 mg Human
In vivo: term pregnant multiparous and
nulliparous women (.38 weeks)
 Bishop score
 Duration of labour in nulliparous women
 Time to delivery in nulliparous
No side effects
Sasaki et al. (1982)
DHEAS 50–200 mg Human
In vivo: term pregnant singleton and twin
pregnancies (.39 weeks)
 Bishop score
(higher correlation of Bishop score with twin
pregnancies)
 E2 levels in maternal serum
(higher correlation of E2 levels with twin
pregnancies)
No change in E1, E3 levels in maternal serum.
Takahashi et al. (1984)
DHEAS 1 mM Rabbit
In vitro: CCs derived from term pregnancy
 Collagenase levels
No effect of E2 or DHEA treatment
Sakyo et al. (1986)
DHEAS 1 mM Rabbit
In vitro: CCs derived from term pregnancy
 Collagenase levels
No effect on collagen levels
Sakyo et al. (1987)
DHEAS 10 mg Rabbit
In vivo: term pregnancy
 Collagenase activity
 Collagen content
Combined DHEAS + IL-8 (100 ng)
treatment-induced neutrophil inﬁltration
Combined treatment produced maximal decrease
in collagen content
Maradny et al. (1996)
DHEAS 100 mg Rat
In vivo: term pregnancy (day 16)
 Collagen content
 Collagenase activity
Yamashita et al.
(1991)
DHEA 0.01 mg/ml
0.1 mg/ml
Human
In vitro: HCF derived from term pregnancy
Increase of IL-8 in conditioned medium
Increase of IL receptor in HCF
Kanayama et al.
(1998)
DHT 2 mg Rat
In vivo: term pregnancy (15 day)
 Cervical resistance
 Proteoglycan
mRNA
Flutamide treatment (10 mg)
 Cervical resistance
 Proteoglycan mRNA
Ji et al. (2008)
DHEAS, dehydroepiandrosterone sulphate; DHT, dihydrotestosterone; HCF, human cervical ﬁbroblast; CCs, cervical cells.
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uterus to 1 unit of injected oxytocin both in vivo and in vitro. The uterus of
T-treated rabbits did not respond to oxytocin administration in contrast
to the uterus of control rabbits. However, the spontaneous contractile
activity of the uteruswas only slightly affected (Robson, 1937). Following
Robson, some other studies have demonstrated similar relaxing effects
of various androgens including T, DHT, A4 and DHEAS on the myome-
trium of non-pregnant rats and non-pregnant and pregnant humans
(Kubli-Garﬁas et al., 1980; Perusquia et al., 1991a, b; Perusquia et al.,
2005). The ﬁndings from these studies are summarized in Table III.
The relaxing effect occurs only in pharmacological concentrations
(micromolar) and is rapid, suggesting non-genomic mechanism of
action (Perusquia et al., 1990; Anderson et al., 2009; Tica et al., 2011).
A logical assumption would be that the observed effect of androgens
might not occur physiologically because physiological androgen concen-
trations are in a nanomolar range. However, understanding the molecu-
lar pathways employed by androgens in modulation of myometrial
relaxation could help in the development of new tocolytic agents to
manage preterm spontaneous contractions. We discuss below the
current evidence for possible molecular mechanisms by which andro-
gens might elicit relaxing effects in myometrium.
Mechanism of MSMC contraction
MSMCs aremyogenic, whichmeans that they can contract spontaneously
(Tomiyasu et al., 1988). The membrane potential in MSMCs is not stable.
Spontaneous depolarization ofmembrane potential, ﬁred by alterations in
membrane currents and ion channels, occurs during pregnancy. A de-
crease in membrane potential triggers myocyte contractile activity and
leads tospontaneouscontractions; conversely, ampliﬁcationofmembrane
potential to a resting 250 mV maintains the uterus in a quiescent state
(Nakajima, 1971; Pressman et al., 1988). The upstroke of MSMCs mem-
brane action potential (i.e. the initial decrease in membrane potential) is
predominantly due to calcium (Ca2+) entry, whereas repolarization
occurs as a result of blockage of Ca2+ channels (Nakajima, 1971). The
key biochemical event in spontaneous MSMC contraction is an increase
in intracellular Ca2+ ([Ca2+]) from 1027 to 1026 M (Horowitz et al.,
1996). This increase is the outcome of extracellular inﬂux of Ca2+ and/
or release of Ca2+ from the sarcoplasmic reticulum (SR). The entry of
Ca2+ is mediated via a variety of Ca2+ channels classiﬁed into voltage-
operated Ca2+ channels (VOCCs) and voltage-independent Ca2+ chan-
nels (including receptor-operated Ca2+ channels, ROCCs) (Wray et al.,
2003, 2005; Floyd andWray,2007;Noble et al., 2009). ROCCsare regu-
latedby an agonist-receptor interaction (Guibert et al., 2008). Receptors
that interact with ROCCs upon ligand binding are G protein coupled
receptors (GPCRs), such as the OXTR. GPCRs can activate the inositol
triphosphate (IP3) pathway leading to release of Ca2+ from SR via activa-
tion of phosphoinositide phospholipase C and hydrolysis of PIP2
(Meldrum et al., 1991). The resulting increase in [Ca2+] leads to forma-
tion of a complex between calmodulin and myosin light chain kinase,
which then phosphorylates light chains on myocin (MLC) (Ito and Hart-
shorne, 1990). The latter event allows binding of actin to myocin leading
to cross-bridge cycling, which then causes contraction (Dillon et al.,
1981). Extrusion of [Ca2+] in MSMCs can occur by reverse processes
and is mediated by two major transporters: plasma membrane Ca2+
ATPase (PMCA) and the Na+/Ca2+ exchange pump (NCX) (Shmigol
et al., 1998). Studies examining mechanisms by which Ca2+ ions are
removed from the cytoplasm in isolated rat MSMCs show that PMCA
accounts for 85% of the Ca2+ efﬂux (Shmigol et al., 1998).
Besides VOCCs, ROCCs, PMCA and NCX, Ca2+ ﬂux is highly inﬂu-
encedbyMSMCmembraneﬂuidity.Aprotonnuclearmagnetic resonance
(NMR)spectroscopystudy investigatingvariousparametersofmyometrial
membrane ﬂuidity at pregnancy, including phospholipid double bonds,
fatty acid chain length and the Ch/phospholipid ratio, reported that
MSMC membrane ﬂuidity is increased with labour (Pulkkinen et al.,
1998). Cell membrane ﬂuidity is modulated by changes in the concentra-
tionofmembraneCh (Shmygol et al., 2007).Ch is a componentof the lipid
bilayer,which integrates into themembrane by placing its steroid ring next
to thehydrocarbonchainsand locating itshydroxyl groupclose to thehead
of phospholipid (van Meer, 1989; Simons and Vaz, 2004; Ikonen, 2008).
High Ch results in a stiff membrane and thus reduces membrane ﬂuidity,
whereas lowCh promotes membrane ﬂuidity. Decreasedmembrane ﬂu-
idity is characterized by inhibition of Ca2+ channels such as VOCCs and
ROCCs (Jennings et al., 1999; Shmygol et al., 2007). Administration of
Ch in vitro decreases [Ca2+] and inhibits the phasic contractions in
MSMCs of rats and humans (Smith et al., 2005; Zhang et al., 2007). On
the other hand, depletion of Ch from the rat MSMC membrane with
methyl-beta-cyclodextrin treatment causes an increase in cell excitability
and contraction (Jennings et al., 1999; Shmygol et al., 2007). High Ch has
beencorrelatedwith increasedactivitiesofNCXandPMCA,which is con-
sistent with their roles in promoting Ca2+ efﬂux (Ortega and Mas-Oliva,
1984; Kutryk and Pierce, 1988; Verbist et al., 1991).
Non-genomic interactions of androgens with the contractilemachinery
Possible interactions of androgens with the MSMC contractile machin-
ery, including interactions with VOCCs, ROCCs, the lipid bilayer, gap
junctions and membrane receptors, which may result in the inhibition
of contraction, are discussed below.
Androgens and VOCCs. High K+ in the extracellular space induces cell
membrane depolarization, which in turn results in opening ofCa2+ chan-
nels (VOCCs) and an increase in [Ca2+]. In addition to the relaxing effect
of androgens on spontaneousmyometrial contractions, 5b-DHT rapidly
relaxes tonic contractions (induced by high K+) and decreases single
MSMC [Ca2+], while removal of the androgen reverses the effect (Per-
usquia et al., 2005).A logical explanationof themechanismof the relaxing
effect of the androgen in that case would be via inhibition of VOCCs.
However, it is not clear whether the effect of androgens involves a phys-
ical interaction with VOCCs or is indirect.
Androgens and ROCCs. Besides VOCCs, there is some evidence that
androgens may be able to block ROCCs. For example, androgens can
relax rat uterine contractions induced by serotonin, oxytocin and acetyl-
choline in vitro (Perusquia, 1991; Perusquia et al., 1991a, b). Oxytocin,
acetylcholine and serotonin receptors are GPCRs. Their activation
leads to subsequent activation of extracellular Ca2+ inﬂux via ROCCs
and/orCa2+ inﬂux from SR via the IP3 pathway (Large, 2002; Thorneloe
and Nelson, 2005). It is possible that androgens exert their effects on
oxytocin-induced contraction via blockage of IP3 pathway and release
of SR Ca2+. However, inhibition of the SR Ca2+ release is not sufﬁcient
for complete blockage of the overall Ca2+ inﬂux (Kupittayanant et al.,
2002). Therefore, a logical assumption would be that androgens block
the ROCC-associated Ca2+ inﬂux rather than components of IP3
pathway. This notion is supported by the inability of T in another study
to inhibit both caffeine- and carbachol- induced Ca2+ release (activators
of IP3-pathway) in coronary SMC (Murphy and Khalil, 1999). Identical
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ﬁndings were reported in isolated rat thoracic aortic strips and porcine
coronary arteries, where T could inhibit K+-induced but not
caffeine-induced contractions (Crews and Khalil, 1999a, b). There are
no data on relaxing effect of androgens on a GPCR agonist-stimulated
contractions (such as oxytocin and prostaglandin FP) induced contrac-
tion in human myometrium.
Androgens and the lipid bilayer. In a similarmanner toCh, it is plausible that
Ch metabolites (including androgens) mediate non-genomic responses
via direct penetration into the cell membrane and reduction in MSMC
membrane ﬂuidity. For example, hydrophobic androgens, such as
DHT and T, have been shown to interact with the phospholipid bilayer
of the negatively charged membrane (Duval et al., 1983; Van Bommel
et al., 1987). Such interactions may impair Ca2+ homeostasis due to an
increase in the activity of PMCA. Regulation of PMCA by androgens is
documented in different tissues. For example, in synaptosomal plasma
membranes, PMCA activity increases 95% following 10 mM of T treat-
ment (Deliconstantinos, 1988). In addition, PMCA activity in kidney is
increased following administration of 10 mM of T, as measured by in
vitro assays where the ATP-dependent Ca2+ ﬂux was determined by
comparison of Ca2+ transport (implying PMCA activity) with and
without exogenous addition of ATP (Dick et al., 2003). In line with the
latter study, androgendeprivation inducedby castration alters the immu-
nochistochemical localizationof PMCA in prostateepithelial cellswith no
changes in mRNA or protein levels (Coviello et al., 2006). Additionally,
the regulation of Ca2+-ATPase in SR activity by T has been explored in
ventricular muscle of orchidectomized (ORX) rats (Witayavanitkul
et al., 2013). In that study, T treatment managed to prevent an
ORX-induced decrease in Ca2+-ATPase activity. Collectively, an alter-
nativemechanism for the non-genomic action of androgens inMSMC re-
laxation is proposed, whereby androgens penetrate the lipid bilayer and
decreasemembrane ﬂuidity, resulting in an increase in PMCAactivity and
Ca2+ efﬂux. However, the effect of androgens on PMCA activity in the
myometrium has not yet been explored and, thus, this hypothesis
remains to be conﬁrmed in this tissue.
Androgens and gap junctions. Increases in single SMC [Ca2+] initiates a syn-
chronized increase in [Ca2+] in adjacent cells, a process mediated by gap
junctions (Loch-Caruso et al., 2003; Brading andBrain, 2011; Boittin et al.,
2013). Gap junction proteins increase the ability of MSMCs to generate
synchronous contractions and mount a synchronous response to hor-
mones or agents in the microenvironment of uterus at labour (Garﬁeld
and Hayashi, 1981; Ikeda et al., 1987). Connexins are gap junction trans-
membrane proteins that assemble to form a gap junction; Con43 is the
predominant connexin involved in the initiation of MSMC contractions
at term (Chow and Lye, 1994). A study in pregnant rats on a high Ch
diet showed that high Ch is associated with a decrease in Con43
protein in the myometrium, suggesting possible implications for uterine
contractility (Elmes et al., 2011). A study in isolated rat cardiac myocytes
demonstrated that gap junctional intracellular communication (GJIC) dis-
turbance, by either silencing the gene for Con43 or by addition of speciﬁc
drugs, such asheptanol, induced a signiﬁcant reduction inCa2+ transients,
suggesting that Con43may be involved in the regulation of basal Ca2+ sig-
nalling in thesecells (Liet al., 2012). Interestingly, anestrogenic compound
.............................................................................................................................................................................................
Table III Studies on the effect of androgen on myometrial contractions.
Androgen Dose Species/tissue Key ﬁndings References
T, DHEA,
androstanediol,
androsterone, A4,
5a-DHT, 5b-DHT
10–100 mM Rat
(non-pregnant)
Ex vivo:myometrial
strips
Spontaneous contractions inhibited rapidly (,30 min) by all androgens
Potency:
androstanediol, androsterone
.5b-DHT. T ¼ A4 ¼ DHEA ¼ 5a-DHT
Kubli-Garﬁas
et al. (1980)
T, DHEA,
androstanediol,
androsterone,
5b-DHT
3–100 mM Rat
(non-pregnant)
Ex vivo:myometrial
strips
Tonic contractions (KCl induced) inhibited rapidly (,30 min) by all
androgens
Potency:
androsterone ¼ androstanediol .5b-DHT. T
Perusquia et al.
(1990)
androstanediol,
androsterone,
5a-DHT, 5b-DHT
3–100 mM Rat
(non-pregnant)
Ex vivo:myometrial
strips
Serotonin-induced contractions inhibited rapidly (,30 min) by all
androgens
Perusquia et al.
(1991a, b)
androstanediol,
androsterone,
5a-DHT, 5b-DHT
3–100 mM Rat
(non-pregnant)
Ex vivo:myometrial
Strips
Acetylcholine-induced contractions inhibited rapidly (,30 min) by all
androgens
Perusquia et al.
(1991a, b)
androstanediol,
androsterone,
5a-DHT, 5b-DHT
3–100 mM Rat
(non-pregnant)
Ex vivo:myometrial
strips
Oxytocin-induced contractions inhibited rapidly (,30 min) by all
androgens
Perusquia
(1991)
T, DHEA, DHT,
5a-DHT, 5b-DHT,
androstanediol,
androsterone
3–100 mM Human (term
pregnant,
non-pregnant)
Ex vivo:myometrial
strips
Spontaneous contractions and tonic contractions (KCl induced)
inhibited rapidly (,30 min) by all androgens
Potency:
5b-DHT. androsterone ¼ DHEA ¼ T . 5a-DHT ¼ androstanediol
Perusquia et al.
(2005)
DHEA, dehydroepiandrosterone; T, testosterone; DHT, dihydrotestosterone; DHEAS, dehydroepiandrosterone sulphate; A4, androstenedione.
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4-OH-TCB has been shown to act in a similar manner to heptanol and
signiﬁcantly block GJIC in rat myometrium (Tsai et al., 1998). What is
more, the same study showed that 4-OH-TCBcould reduce contractions
of ratmyometrial strips, suggesting that the relaxingeffectof 4-OH-TCB is
mediated throughblockageofGJIC.There is evidence that androgens can
inﬂuenceGJIC in isolated rat cardiacmyocytesandSertoli cells (Pluciennik
et al., 1996). One study demonstrated a dose-dependent (1–25 mM)
inhibitory effect of T propionate on GJIC, which was reversed by T with-
drawal and was unaffected by pre-incubation with AR antagonist, again
implying a non-genomic effect of T (Pluciennik et al., 1996). Based on
these studies, it is tempting to hypothesize that androgens may induce
relaxation of myometrium via direct interaction with the membrane
proteolipidic structure,whichmight alterdirectlyor indirectly the function
of gap junction channels; however, more evidence in needed.
Androgens and ARs.A role for ARs in inhibition ofmyometrial contraction
has been investigated (Perusquia et al., 2005). Flutamide-inducedAR an-
tagonism failed to inhibit the relaxing effect of 5b-DHT (Perusquia et al.,
2005).Notably, in that study, ﬂutamidewas administeredata signiﬁcantly
lower concentration (10 mM) than the concentration of 5b-DHT
(100 mM), thus it is not clearwhether nuclearAR is involved in the relaxing
effect. However, the rapid action of androgens on myometrial relaxation
makes a genomic mechanism unlikely. On the other hand, a few reports
have now demonstrated that AR can be recruited in non-genomic
actions of androgens (reviewed in Hammes and Levin, 2011). This mech-
anism involves the largely unexplored membrane AR (mAR). The mAR is
hypothesized to be either a GPCR or a classic AR lacking a DNA-binding
site; the latter is thought to have greater afﬁnity for androgens compared
with nAR (Konoplya and Popoff, 1992; Foradori et al., 2008; Yang et al.,
2011). A study on airway SMCs showed that in addition to T, treatments
with membrane impermable T conjugated to BSA (TBSA) could inhibit
contraction, suggesting that T exerts its effects on the outer aspect of
the membrane rather than in the cytoplasm (Kouloumenta et al., 2006).
However, the downstream mechanism of mAR activation in that study
was unclear. The structure of mAR is yet to be characterized in
mammals and it is unknown whether it is utilized by androgens to inhibit
MSMC contraction (Thomas et al., 2006).
Collectively, the above studies allow us to hypothesize that androgen-
inducedMSMCrelaxation ismediated via penetrationof the androgen into
the lipid bilayer where it affects molecules critical for generation of Ca2+
transients, including VOCCs, ROCCs, gap junctions and PMCA (Fig. 4).
Conclusions
There is growing evidence that androgens, which increase throughout
gestation, might play a functional role in the physiology of pregnancy in
parallel with the well-established roles of progestins and estrogens.
Herein we reviewed what is currently known about roles played by
androgens in two critical systems in biology of pregnancy and parturition,
cervical remodelling and myometrial function.
There is evidence from in vivo and in vitro studies that androgens
promote CR and, thus, assist initiation of labour. On the other hand,
androgens appear to be effective in in vitro tocolysis of myometrial con-
tractions. Although the action of androgens on cervical remodelling is
possibly mediated via classical activation of genomic signalling via AR, it
is unlikely that the same mechanism mediates androgen effects in myo-
metrial contractility. In contrast, there is more evidence that AR acting
within the nucleus is involved in the proliferation of MSMCs and, thus,
may be important for the growth of myometrium at the beginning of
pregnancy. Further investigations are required to fully understand the
molecular events regulated by androgens in cervix and myometrium
and their interplay with other signalling pathways. These investigations
should potentially utilize animalmodels of adverse pregnancy outcomes,
where targeted administration of androgens to either cervix or myome-
triumcouldbehighly informative. In conclusion, research into the roles of
androgens in cervical andmyometrial function during pregnancy and par-
turition has the potential to inform new therapeutic strategies for man-
agement of pregnancy complications, such as PTL and PTB.
Acknowledgement
We are grateful to Mr Ronnie Grant for graphical support.
Authors’ roles
S.M., P.T.K.S. and J.E.N. made substantial contributions to the concep-
tion, design, analysis, drafting and revision of the article and approved
the ﬁnal version to be published. The authors declare that there are no
conﬂicts of interest.
Funding
The authors are grateful for funding from theUniversity of Edinburgh Prin-
cipal’s Career Development Research Fund and from the Albert McKern
Bequest which jointly funded a PhD studentship to SM. Funding to pay the
Open Access publication charges for this article was provided by the
Albert McKern Bequest.
Figure 4 Hypothetical targets of androgens in modulation of MSMC
relaxation. Androgens are hypothesized to interact with contractile
machinery of MSMCs via penetration into the lipid bilayer. This might
promote PMCA to induce rapid Ca2+ efﬂux, block VOCCs and ROCCs
and impair IGJC via effects on the gap junctions. PMCA, Ca2+ ATPase;
VOCC, voltage-operated Ca2+ channels; ROCC, receptor-operated
Ca2+ channels; IGJC, intercellular gap junctional communication.
12 Makieva et al.
 at Edinburgh U
niversity on M
ay 19, 2014
http://hum
upd.oxfordjournals.org/
D
ow
nloaded from
 
Conﬂict of interest
None declared.
References
Abbott DH, Bruns CR, Barnett DK, Dunaif A, Goodfriend TL, Dumesic DA,
Tarantal AF. Experimentally induced gestational androgen excess disrupts
glucoregulation in rhesus monkey dams and their female offspring. Am J Physiol
Endocrinol Metab 2010;299:E741–E751.
Abe T, Ono S, Igarashi M, Akira S, Watanabe A, Takeshita T. Conservative
management of hyperreactio luteinalis: a case report. J Nippon Med Sch 2011;
78:241–245.
Abraham GE. Ovarian and adrenal contribution to peripheral androgens during the
menstrual cycle. J Clin Endocrinol Metab 1974;39:340–346.
Ackerman CM, Lowe LP, Dyer AR, Hayes MG, Metzger BE, Lowe WL, Urbanek M,
Group HSCR. Maternal testosterone levels are associated with C-peptide levels in
the Mexican American subset of the Hyperglycemia and Adverse Pregnancy
Outcome (HAPO) Study cohort. Horm Metab Res 2013;45:617–620.
Albrecht ED,HaskinsAL, PepeGJ. The inﬂuence of fetectomyatmidgestation upon the
serum concentrations of progesterone, estrone, and estradiol in baboons.
Endocrinology 1980;107:766–770.
Albrecht ED, Crenshaw MC Jr, Pepe GJ. The effect of estrogen on placental delivery
after fetectomy in baboons. Am J Obstet Gynecol 1989;160:237–241.
Albrecht ED, Pepe GJ. Suppression of maternal adrenal dehydroepiandrosterone and
dehydroepiandrosterone sulfate production by estrogen during baboon pregnancy.
J Clin Endocrinol Metab 1995;80:3201–3208.
Alﬁrevic Z, Stampalija T, Roberts D, Jorgensen AL. Cervical stitch (cerclage) for
preventing preterm birth in singleton pregnancy. Cochrane Database Syst Rev 2012;
4:CD008991.
AmoahC,YassinA,CockayneE,BirdA.Hyperreactio luteinalis in pregnancy. Fertil Steril
2011;95:2429, e2421–2423.
Anderson L, MartinW, Higgins C, Nelson SM, Norman JE. The effect of progesterone
on myometrial contractility, potassium channels, and tocolytic efﬁcacy. Reprod Sci
2009;16:1052–1061.
Angioni S, Portoghese E, Milano F, Melis GB, Fulghesu AM. Hirsutism and
hyperandrogenism associated with hyperreactio luteinalis in a singleton
pregnancy: a case report. Gynecol Endocrinol 2007;23:248–251.
Annamalai AK, Hoveyda F, Williams RM, Patterson A, Simpson HL. Hyperreactio
luteinalis. QJM 2011;104:807–808.
Astolﬁ P, Zonta LA. Risks of preterm delivery and association with maternal age, birth
order, and fetal gender. Hum Reprod 1999;14:2891–2894.
Atis A, Cifci F, Aydin Y, Ozdemir G, Goker N. Hyperreactio luteinalis with
preeclampsia. J Emerg Trauma Shock 2010;3:298.
Avvakumov GV, Cherkasov A, Muller YA, Hammond GL. Structural analyses of sex
hormone-binding globulin reveal novel ligands and function. Mol Cell Endocrinol
2010;316:13–23.
Baird DT, Horton R, Longcope C, Tait JF. Steroid dynamics under steady-state
conditions. Recent Prog Horm Res 1969;25:611–664.
BammannBL,CoulamCB, JiangNS. Total and free testosteroneduring pregnancy.Am J
Obstet Gynecol 1980;137:293–298.
Bardin CW, Brown T, Isomaa VV, Janne OA. Progestins can mimic, inhibit and
potentiate the actions of androgens. Pharmacol Ther 1983;23:443–459.
Belisle S, Osathanondh R, Tulchinsky D. The effect of constant infusion of unlabeled
dehydroepiandrosterone sulfate on maternal plasma androgens and estrogens.
J Clin Endocrinol Metab 1977;45:544–550.
Belisle S, Lehoux JG, Brault J. Themetabolismof androstenedione in human pregnancy:
the use of constant infusion of unlabeled steroid to assess its metabolic clearance
rate, its production rate, and its conversion into androgens and estrogens. Am J
Obstet Gynecol 1980a;136:1030–1035.
Belisle S, Schiff I, Tulchinsky D. The use of constant infusion of unlabeled
dehydroepiandrosterone for the assessment of its metabolic clearance rate, its
half-life, and its conversion into estrogens. J Clin Endocrinol Metab 1980b;
50:117–121.
Berger NG, Repke JT, Woodruff JD. Markedly elevated serum testosterone in
pregnancy without fetal virilization. Obstet Gynecol 1984;63:260–262.
Bethin KE, Nagai Y, Sladek R, Asada M, Sadovsky Y, Hudson TJ, Muglia LJ. Microarray
analysis of uterine gene expression in mouse and human pregnancy.Mol Endocrinol
2003;17:1454–1469.
Birrell SN, Butler LM, Harris JM, Buchanan G, Tilley WD. Disruption of androgen
receptor signaling by synthetic progestins may increase risk of developing breast
cancer. FASEB J 2007;21:2285–2293.
Blencowe H, Cousens S, Oestergaard MZ, Chou D, Moller AB, Narwal R, Adler A,
Vera Garcia C, Rohde S, Say L et al.. National, regional, and worldwide
estimates of preterm birth rates in the year 2010 with time trends since 1990
for selected countries: a systematic analysis and implications. Lancet 2012;
379:2162–2172.
Boittin FX, Alonso F, Le Gal L, Allagnat F, Beny JL, Haeﬂiger JA. Connexins and M3
muscarinic receptors contribute to heterogeneous Ca(2+) signaling in mouse
aortic endothelium. Cell Physiol Biochem 2013;31:166–178.
Bordallo J, de Boto MJ, Meana C, Velasco L, Bordallo C, Suarez L, Cantabrana B,
Sanchez M. Modulatory role of endogenous androgens on airway smooth muscle
tone in isolated guinea-pig and bovine trachea; involvement of
beta2-adrenoceptors, the polyamine system and external calcium. Eur J Pharmacol
2008;601:154–162.
Brading AF, Brain KL. Ion channel modulators and urinary tract function. Handb Exp
Pharmacol 2011;202:375–393.
Brannian JD, Stouffer RL. Progesterone production by monkey luteal cell
subpopulations at different stages of the menstrual cycle: changes in agonist
responsiveness. Biol Reprod 1991;44:141–149.
Braunstein GD, Rasor J, Danzer H, Adler D, Wade ME. Serum human chorionic
gonadotropin levels throughout normal pregnancy. Am J Obstet Gynecol 1976;
126:678–681.
Brenner RM, SlaydenOD,NayakNR, BairdDT,CritchleyHO.A role for the androgen
receptor in the endometrial antiproliferative effects of progesterone antagonists.
Steroids 2003;68:1033–1039.
Burger HG. Androgen production in women. Fertil Steril 2002;77(Suppl. 4):S3–S5.
Buster JE, Chang RJ, Preston DL, Elashoff RM, Cousins LM, Abraham GE, Hobel CJ,
Marshall JR. Interrelationships of circulating maternal steroid concentrations in
third trimester pregnancies. II. C18 and C19 steroids: estradiol, estriol,
dehydroepiandrosterone, dehydroepiandrosterone sulfate, delta 5-androstenediol,
delta 4-androstenedione, testosterone, and dihydrotestosterone. J Clin Endocrinol
Metab 1979;48:139–142.
CabezaM,Gutierrez E,MirandaR,Heuze I, Bratoeff E, FloresG,RamirezE.Androgenic
and anti-androgenic effects of progesterone derivatives with different halogens as
substituents at the C-6 position. Steroids 1999;64:413–421.
Cantineau R, Kremers P, De Graeve J, Gielen JE, Lambotte R. 15- and
16-hydroxylations of androgens and estrogens in the human fetal liver: a critical
step in estetrol biosynthesis. J Steroid Biochem 1985;22:195–201.
Carlsen SM, JacobsenG, Bjerve KS. Androgen levels in pregnant women decreasewith
increasing maternal age. Scand J Clin Lab Invest 2003;63:23–26.
Carlsen SM, JacobsenG,RomundstadP.Maternal testosterone levels during pregnancy
are associated with offspring size at birth. Eur J Endocrinol 2006;155:365–370.
Carson DJ, Okuno A, Lee PA, Stetten G, Didolkar SM, Migeon CJ. Amniotic ﬂuid
steroid levels. Fetuses with adrenal hyperplasia, 46,XXY fetuses, and normal
fetuses. Am J Dis Child 1982;136:218–222.
Castracane VD, Asch RH. Testosterone and androstenedione in premature ovarian
failure pregnancies: evidence for an ovarian source of androgens in early
pregnancy. Hum Reprod 1995;10:677–680.
Castracane VD, Stewart DR, Gimpel T, Overstreet JW, Lasley BL. Maternal serum
androgens in human pregnancy: early increases within the cycle of conception.
Hum Reprod 1998;13:460–464.
Charest NJ, Zhou ZX, Lubahn DB, Olsen KL, Wilson EM, French FS. A frameshift
mutation destabilizes androgen receptor messenger RNA in the Tfm mouse. Mol
Endocrinol 1991;5:573–581.
Chevalier M, Gilbert G, Lory P, Marthan R, Quignard JF, Savineau JP.
Dehydroepiandrosterone (DHEA) inhibits voltage-gated T-type calcium channels.
Biochem Pharmacol 2012;83:1530–1539.
Chou TM, Sudhir K, Hutchison SJ, Ko E, Amidon TM, Collins P, Chatterjee K.
Testosterone induces dilation of canine coronary conductance and resistance
arteries in vivo. Circulation 1996;94:2614–2619.
Chow L, Lye SJ. Expression of the gap junction protein connexin-43 is increased in the
human myometrium toward term and with the onset of labor. Am J Obstet Gynecol
1994;170:788–795.
Androgens in pregnancy: roles in parturition 13
 at Edinburgh U
niversity on M
ay 19, 2014
http://hum
upd.oxfordjournals.org/
D
ow
nloaded from
 
Corbould A. Effects of androgens on insulin action in women: is androgen excess a
component of female metabolic syndrome? Diabetes Metab Res Rev 2008;
24:520–532.
Costarella CE, Stallone JN, Rutecki GW, Whittier FC. Testosterone causes direct
relaxation of rat thoracic aorta. J Pharmacol Exp Ther 1996;277:34–39.
Coviello AD, Lakshman K, Mazer NA, Bhasin S. Differences in the apparent metabolic
clearance rate of testosterone in young and older men with gonadotropin
suppression receiving graded doses of testosterone. J Clin Endocrinol Metab 2006;
91:4669–4675.
Crews JK, Khalil RA. Antagonistic effects of 17 beta-estradiol, progesterone, and
testosterone on Ca2+ entry mechanisms of coronary vasoconstriction.
Arterioscler Thromb Vasc Biol 1999a;19:1034–1040.
Crews JK, Khalil RA. Gender-speciﬁc inhibition of Ca2+ entry mechanisms of arterial
vasoconstriction by sex hormones. Clin Exp Pharmacol Physiol 1999b;26:707–715.
CrisostoN, EchiburuB,MaliqueoM, PerezV, LadrondeGuevaraA, Preisler JSanchez F,
Sir-Petermann T. Improvement of hyperandrogenism and hyperinsulinemia during
pregnancy in women with polycystic ovary syndrome: possible effect in the ovarian
follicular mass of their daughters. Fertil Steril 2012;97:218–224.
Dahl SK, Thomas MA, Williams DB, Robins JC. Maternal virilization due to luteoma
associated with delayed lactation. Fertil Steril 2008;90:2006, e2017–2009.
Dasgupta E, SinghG. Vaginalmisoprostol vs vaginal misoprostol with estradiol for labor
induction: a prospective double blind study. J Obstet Gynaecol India 2012;62:47–51.
DawoodMY, Saxena BB. Testosterone and dihydrotestosterone in maternal and cord
blood and in amniotic ﬂuid. Am J Obstet Gynecol 1977;129:37–42.
DeliconstantinosG. Structure activity relationship of cholesterol and steroid hormones
with respect to their effects on the Ca2+-stimulated ATPase and lipid ﬂuidity of
synaptosomal plasma membranes from dog and rabbit brain. Comp Biochem
Physiol B 1988;89:585–594.
Denayer S,HelsenC,Thorrez L,HaelensA,Claessens F. The rules ofDNArecognition
by the androgen receptor.Mol Endocrinol 2010;24:898–913.
DespresG,RigaudiereN,Delost P.Changes in themetabolic clearance rate andplasma
production rate of testosterone in the pregnant guinea-pig. Steroids 1982;
39:703–710.
Dewailly D. Androgen excess in women: not just a cosmetic problem. Ann Endocrinol
(Paris) 2010;71:1.
Diamanti-Kandarakis E, Alexandraki K, Piperi C, Protogerou A, Katsikis I, Paterakis T,
Lekakis J, PanidisD. Inﬂammatory and endothelial markers inwomenwith polycystic
ovary syndrome. Eur J Clin Invest 2006;36:691–697.
Dick IM, Liu J, Glendenning P, Prince RL. Estrogen and androgen regulation of plasma
membrane calcium pump activity in immortalized distal tubule kidney cells. Mol
Cell Endocrinol 2003;212:11–18.
Diez d’Aux RC, Pearson Murphy BE. Androgens in the human fetus. J Steroid Biochem
1974;5:207–210.
Dillon PF, Aksoy MO, Driska SP, Murphy RA. Myosin phosphorylation and the
cross-bridge cycle in arterial smooth muscle. Science 1981;211:495–497.
Duval D,Durant S, Homo-Delarche F.Non-genomic effects of steroids. Interactions of
steroid molecules with membrane structures and functions. Biochim Biophys Acta
1983;737:409–442.
EdmanCD,ToofanianA,MacDonaldPC,GantNF.Placental clearance rateofmaternal
plasma androstenedione through placental estradiol formation: an indirect method
of assessing uteroplacental blood ﬂow. Am J Obstet Gynecol 1981;141:1029–1037.
Ekman G, Malmstrom A, Uldbjerg N, Ulmsten U. Cervical collagen: an important
regulator of cervical function in term labor. Obstet Gynecol 1986;67:633–636.
Ekman-OrdebergG, StjernholmY,WangH, Stygar D, Sahlin L. Endocrine regulation of
cervical ripening in humans—potential roles for gonadal steroids and insulin-like
growth factor-I. Steroids 2003;68:837–847.
Elbaum DJ, Keyes PL. Synthesis of 17beta-estradiol by isolated ovarian tissues of the
pregnant rat: aromatization in the corpus luteum. Endocrinology 1976;99:573–579.
El Maradny E, Kanayama N, Halim A, Maehara K, Sumimoto K, Terao T. Biochemical
changes in the cervical tissue of rabbit induced by interleukin-8, interleukin-1beta,
dehydroepiandrosterone sulphate and prostaglandin E2: a comparative study.
Hum Reprod 1996;11:1099–1104.
Elmes MJ, Tan DS, Cheng Z, Wathes DC, McMullen S. The effects of a high-fat,
high-cholesterol diet on markers of uterine contractility during parturition in the
rat. Reproduction 2011;141:283–290.
ErkinheimoTL, SaukkonenK,NarkoK, Jalkanen J, YlikorkalaO,RistimakiA. Expression
of cyclooxygenase-2 and prostanoid receptors by human myometrium. J Clin
Endocrinol Metab 2000;85:3468–3475.
Escobar JC, Patel SS, Beshay VE, Suzuki T, Carr BR. The human placenta expresses
CYP17 and generates androgens de novo. J Clin Endocrinol Metab 2011;
96:1385–1392.
Escobar-Morreale HF. Diagnosis and management of hirsutism. Ann N Y Acad Sci 2010;
1205:166–174.
Escobar-Morreale HF, Carmina E, Dewailly D, Gambineri A, Kelestimur F, Moghetti P,
Pugeat M, Qiao J, Wijeyaratne CN, Witchel SF et al.. Epidemiology, diagnosis and
management of hirsutism: a consensus statement by the Androgen Excess and
Polycystic Ovary Syndrome Society. Hum Reprod Update 2012;18:146–170.
Espinos JJ, Corcoy R, Roca B, Rodriguez-Espinosa J, Calaf J. Serum insulin and androgen
concentrations inwomenwith historiesof gestational diabetes.MedClin (Barc)1992;
98:445–448.
Fata JE, HoAT, Leco KJ, Moorehead RA, Khokha R. Cellular turnover and extracellular
matrix remodeling in female reproductive tissues: functions of metalloproteinases
and their inhibitors. Cell Mol Life Sci 2000;57:77–95.
Figueroa JP,HonnebierMB, BiniendaZ,Wimsatt J, Nathanielsz PW. Effect of a 48-hour
intravenous delta 4-androstenedione infusion on the pregnant rhesusmonkey in the
last third of gestation: changes in maternal plasma estradiol concentrations and
myometrial contractility. Am J Obstet Gynecol 1989;161:481–486.
Fisch B, Margara RA,Winston RM, Hillier SG. Cellular basis of luteal steroidogenesis in
the human ovary. J Endocrinol 1989;122:303–311.
Floyd R, Wray S. Calcium transporters and signalling in smooth muscles. Cell Calcium
2007;42:467–476.
Foradori CD, Weiser MJ, Handa RJ. Non-genomic actions of androgens. Front
Neuroendocrinol 2008;29:169–181.
Foulk RA, Martin MC, Jerkins GL, Laros RK. Hyperreactio luteinalis differentiated from
severe ovarian hyperstimulation syndrome in a spontaneously conceivedpregnancy.
Am J Obstet Gynecol 1997;176:1300–1302; discussion 1302–1304.
Franczak A. Endometrial and myometrial secretion of androgens and estrone during
early pregnancy and luteolysis in pigs. Reprod Biol 2008;8:213–228.
Fuchs AR, Fuchs F, Husslein P, Soloff MS. Oxytocin receptors in the human uterus
during pregnancy and parturition. Am J Obstet Gynecol 1984;150:734–741.
Fuller PJ, Pettigrew IG, Pike JW, Stockigt JR. An adrenal adenoma causing virilization of
mother and infant. Clin Endocrinol (Oxf) 1983;18:143–153.
Gabbiani G, Schmid E,Winter S, Chaponnier C, de Ckhastonay C, Vandekerckhove J,
Weber K, Franke WW. Vascular smooth muscle cells differ from other smooth
muscle cells: predominance of vimentin ﬁlaments and a speciﬁc alpha-type actin.
Proc Natl Acad Sci USA 1981;78:298–302.
Gant NF, Hutchinson HT, Siiteri PK, MacDonald PC. Study of the metabolic clearance
rate of dehydroisoandrosterone sulfate in pregnancy. Am J Obstet Gynecol 1971;
111:555–563.
Garﬁeld RE, Hayashi RH. Appearance of gap junctions in the myometrium of women
during labor. Am J Obstet Gynecol 1981;140:254–260.
Gatongi DK, Madhvi G, Tydeman G, Hasan A. A case of hyperreactio luteinalis
presenting with eclampsia. J Obstet Gynaecol 2006;26:465–467.
Ghayee HK, Auchus RJ. Basic concepts and recent developments in human steroid
hormone biosynthesis. Rev Endocr Metab Disord 2007;8:289–300.
Ghorashi V, Sheikhvatan M. The relationship between serum concentration of free
testosterone and pre-eclampsia. Endokrynol Pol 2008;59:390–392.
Ghule VV, Gray C, Galimberti A, Anumba DO. Prostaglandin-induced cervical
remodelling in humans in the ﬁrst trimester is associated with increased
expression of speciﬁc tight junction, but not gap junction proteins. J Transl Med
2012;10:40.
Goodyer CG, Branchaud CL. Regulation of hormone production in the human
feto-placental unit. Ciba Found Symp 1981;86:89–123.
Grgic O, Radakovic B, Barisic D. Hyperreactio luteinalis could be a risk factor for
development of HELLP syndrome: case report. Fertil Steril 2008;90:2008, e2013–
2006.
Guibert C, Ducret T, Savineau JP. Voltage-independent calcium inﬂux in smooth
muscle. Prog Biophys Mol Biol 2008;98:10–23.
Gurpide E. Experimental designs used to estimate rates of steroid production and
metabolism in vivo and in vitro. Ann N Y Acad Sci 1990;595:165–172.
Haas DM, Caldwell DM, Kirkpatrick P, McIntosh JJ, Welton NJ. Tocolytic therapy for
preterm delivery: systematic review and network meta-analysis. BMJ 2012;
345:e6226.
Haimov-Kochman R, Yanai N, Yagel S, Amsalem H, Lavy Y, Hurwitz A. Spontaneous
ovarian hyperstimulation syndrome and hyperreactio luteinalis are entities in
continuum. Ultrasound Obstet Gynecol 2004;24:675–678.
14 Makieva et al.
 at Edinburgh U
niversity on M
ay 19, 2014
http://hum
upd.oxfordjournals.org/
D
ow
nloaded from
 
Hall PF, Chen S, Nakajin S, Shinoda M, Shively JE. Puriﬁcation and characterization of
aromatase from human placenta. Steroids 1987;50:37–50.
Hammes SR, Levin ER. Minireview: recent advances in extranuclear steroid receptor
actions. Endocrinology 2011;152:4489–4495.
Hammond GL. Diverse roles for sex hormone-binding globulin in reproduction. Biol
Reprod 2011;85:431–441.
HaqAN.Hyperreactio luteinalis associatedwith pregnancy inducedhypertension. J Coll
Physicians Surg Pak 2010;20:137–139.
Hensleigh PA, Carter RP, Grotjan HE Jr. Fetal protection against masculinization
with hyperreactio luteinalis and virilization. J Clin Endocrinol Metab 1975;
40:816–823.
Hirano M. Formation and biological activity of estriol in placenta. Tohoku J Exp Med
1961;75:89–102.
Hodgins MB. Binding of androgens in 5 alpha-reductase-deﬁcient human genital skin
ﬁbroblasts: inhibition by progesterone and its metabolites. J Endocrinol 1982;
94:415–427.
Holt HB, Medbak S, Kirk D, Guirgis R, Hughes I, Cummings MH, Meeking DR.
Recurrent severe hyperandrogenism during pregnancy: a case report. J Clin Pathol
2005;58:439–442.
Horowitz A, Menice CB, Laporte R, Morgan KG. Mechanisms of smooth muscle
contraction. Physiol Rev 1996;76:967–1003.
Hughes IA, Davies JD, Bunch TI, Pasterski V, Mastroyannopoulou K, MacDougall J.
Androgen insensitivity syndrome. Lancet 2012;380:1419–1428.
Ikeda M, Shibata Y, Yamamoto T. Rapid formation of myometrial gap junctions during
parturition in the unilaterally implanted rat uterus. Cell Tissue Res 1987;
248:297–303.
IkonenE.Cellular cholesterol trafﬁcking andcompartmentalization.NatRevMol Cell Biol
2008;9:125–138.
ItoM,HartshorneDJ. Phosphorylation of myosin as a regulatorymechanism in smooth
muscle. Prog Clin Biol Res 1990;327:57–72.
Ito T, Horton R. The source of plasma dihydrotestosterone in man. J Clin Invest 1971;
50:1621–1627.
Jasonni VM, Bonavia M, Lodi S, Preti S, Bulletti C, Flamigni C. Androstenedione
metabolism in human uterine tissues: endometrium, myometrium and
leiomyoma. J Steroid Biochem 1982;17:547–551.
Jennings LJ,XuQW,FirthTA,NelsonMT,MaweGM.Cholesterol inhibits spontaneous
action potentials and calcium currents in guinea pig gallbladder smooth muscle. Am J
Physiol 1999;277:G1017–G1026.
Ji H, Dailey TL, Long V, Chien EK. Androgen-regulated cervical ripening: a structural,
biomechanical, and molecular analysis. Am J Obstet Gynecol 2008;198:543, e541–
549.
Ji H, Long V, Briody V, Chien EK. Progesterone modulates integrin {alpha}2 (ITGA2)
and {alpha}11 (ITGA11) in the pregnant cervix. Reprod Sci 2011;18:156–163.
Joseph DR. Structure, function, and regulation of androgen-binding protein/sex
hormone-binding globulin. Vitam Horm 1994;49:197–280.
KanayamaN, El Maradny E, Goto J, Terao T. Effect of dehydroepiandrosterone sulfate
on interleukin-8 receptor during cervical ripening. Eur J Endocrinol 1998;
138:587–593.
Kanova N, Bicikova M. Hyperandrogenic states in pregnancy. Physiol Res 2011;
60:243–252.
Karjalainen MK, Huusko JM, Ulvila J, Sotkasiira J, Luukkonen A, Teramo K, Plunkett J,
Anttila V, Palotie A, Haataja R et al. A potential novel spontaneous preterm birth
gene, AR, identiﬁed by linkage and association analysis of X chromosomal
markers. PLoS One 2012;7:e51378.
Keelan JA,Mattes E, TanH,DinanA,Newnham JP,WhitehouseAJ, JacobyP,HickeyM.
Androgen concentrations in umbilical cord blood and their association with
maternal, fetal and obstetric factors. PLoS One 2012;7:e42827.
Konoplya EF, Popoff EH. Identiﬁcation of the classical androgen receptor in male rat
liver and prostate cell plasma membranes. Int J Biochem 1992;24:1979–1983.
Kouloumenta V, Hatziefthimiou A, Paraskeva E, Gourgoulianis K, Molyvdas PA.
Non-genomic effect of testosterone on airway smooth muscle. Br J Pharmacol
2006;149:1083–1091.
Koyuncu F, Aksoy S, Karanﬁl C, Demir N, Bozkurt K, Tuncay G. [The effect of
dehydroepiandrosterone sulfate on cervical maturation during pregnancy.
J Gynecol Obstet Biol Reprod (Paris) 1995;24:630–633.
Kubli-Garﬁas C, Lopez-Fiesco A, Pacheco-Cano MT, Ponce-Monter H, Bondani A. In
vitro effects of androgens upon the spontaneous rat uterine contractility. Steroids
1980;35:633–641.
Kupittayanant S, Luckas MJ, Wray S. Effect of inhibiting the sarcoplasmic reticulum on
spontaneous and oxytocin-induced contractions of human myometrium. BJOG
2002;109:289–296.
Kutryk MJ, Pierce GN. Stimulation of sodium-calcium exchange by cholesterol
incorporation into isolated cardiac sarcolemmal vesicles. J Biol Chem 1988;
263:13167–13172.
Labrie F, Martel C, Balser J. Wide distribution of the serum dehydroepiandrosterone
and sex steroid levels in postmenopausal women: role of the ovary? Menopause
2011;18:30–43.
Laherty RF, Rotten D, Yamamoto M, Jaffe RB. Effects of oestradiol and prolactin on
progesterone production by rhesus monkey luteal cells in vitro. Acta Endocrinol
(Copenh) 1985;108:266–272.
Lang F, Alevizopoulos K, Stournaras C. Targeting membrane androgen receptors in
tumors. Expert Opin Ther Targets 2013;17:951–963.
Large WA. Receptor-operated Ca2(+)-permeable nonselective cation channels in
vascular smooth muscle: a physiologic perspective. J Cardiovasc Electrophysiol
2002;13:493–501.
Larmon JE, Magann EF, Dickerson GA, Morrison JC. Outpatient cervical ripening with
prostaglandin E2 and estradiol. J Matern Fetal Neonatal Med 2002;11:113–117.
Leppert PC. Anatomy and physiology of cervical ripening. Clin Obstet Gynecol 1995;
38:267–279.
LiC,MengQ,YuX, JingX,XuP, LuoD.Regulatoryeffectof connexin43onbasalCa2+
signaling in rat ventricular myocytes. PLoS One 2012;7:e36165.
Likis FE, Edwards DR, Andrews JC, Woodworth AL, Jerome RN, Fonnesbeck CJ,
McKoy JN, Hartmann KE. Progestogens for preterm birth prevention: a
systematic review and meta-analysis. Obstet Gynecol 2012;120:897–907.
Liu YX, Hsueh AJ. Synergism between granulosa and theca-interstitial cells in estrogen
biosynthesis by gonadotropin-treated rat ovaries: studies on the two-cell,
two-gonadotropin hypothesis using steroid antisera. Biol Reprod 1986;35:27–36.
Liu L, Li Y, XieN, ShynlovaO, Challis JR, Slater D, Lye S, Dong X. Proliferative action of
the androgen receptor in human uterine myometrial cells—a key regulator for
myometrium phenotype programming. J Clin Endocrinol Metab 2013;98:218–227.
Loch-Caruso RK, Criswell KA, Grindatti CM, Brant KA. Sustained inhibition of rat
myometrial gap junctions and contractions by lindane. Reprod Biol Endocrinol 2003;
1:62.
LongcopeC.Adrenal and gonadal androgen secretion in normal females.Clin Endocrinol
Metab 1986;15:213–228.
Longcope C. Dehydroepiandrosterone metabolism. J Endocrinol 1996;150(Suppl.):
S125–S127.
Lorzadeh N, Kazemirad S. The effects of fetal gender on serum human chorionic
gonadotropin and testosterone in normotensive and preeclamptic pregnancies.
J Pregnancy 2012;2012:874290.
Loudon JA, Sooranna SR, Bennett PR, Johnson MR. Mechanical stretch of human
uterine smooth muscle cells increases IL-8 mRNA expression and peptide
synthesis.Mol Hum Reprod 2004;10:895–899.
Lubahn DB, Joseph DR, Sullivan PM, Willard HF, French FS, Wilson EM. Cloning of
human androgen receptor complementary DNA and localization to the X
chromosome. Science 1988;240:327–330.
Ludwig M, Beck A, Wickert L, Bolkenius U, Tittel B, Hinkel K, Bidlingmaier F. Female
pseudohermaphroditism associated with a novel homozygous G-to-A
(V370-to-M) substitution in the P-450 aromatase gene. J Pediatr Endocrinol Metab
1998;11:657–664.
Lye SJ, Mitchell J, Nashman N, Oldenhof A, Ou R, Shynlova O, Langille L. Role of
mechanical signals in the onset of term and preterm labor. Front Horm Res 2001;
27:165–178.
LynnKN, Steinkeler JA,Wilkins-Haug LE, BensonCB.Hyperreactio luteinalis (enlarged
ovaries) during the second and third trimesters of pregnancy: common clinical
associations. J Ultrasound Med 2013;32:1285–1289.
Macleod DJ, Sharpe RM,Welsh M, Fisken M, Scott HM, Hutchison GR, Drake AJ, van
den Driesche S. Androgen action in the masculinization programming window and
development of male reproductive organs. Int J Androl 2010;33:279–287.
MahendrooMS, RussellDW.Male and female isoenzymesof steroid 5alpha-reductase.
Rev Reprod 1999;4:179–183.
Mahendroo MS, Cala KM, Russell DW. 5 alpha-reduced androgens play a key role in
murine parturition. Mol Endocrinol 1996;10:380–392.
Mahendroo MS, Porter A, Russell DW, Word RA. The parturition defect in steroid
5alpha-reductase type 1 knockout mice is due to impaired cervical ripening. Mol
Endocrinol 1999;13:981–992.
Androgens in pregnancy: roles in parturition 15
 at Edinburgh U
niversity on M
ay 19, 2014
http://hum
upd.oxfordjournals.org/
D
ow
nloaded from
 
Manabe Y, Sakaguchi M, Nakajima A. Initiation of uterine contractions by purely
mechanical stretching of the uterus at midpregnancy. Int J Biol Res Pregnancy 1981;
2:63–69.
Maradny E, KanayamaN,Maehara K, Kobayashi T, Terao T. Dehydroepiandrosterone
sulfate potentiates the effect of interleukin-8 on the cervix. Gynecol Obstet Invest
1996;42:191–195.
Marchetti PM, Barth JH. Clinical biochemistry of dihydrotestosterone. Ann Clin Biochem
2013;50:95–107.
Masuyama H, Tateishi Y, Matsuda M, Hiramatrsu Y. Hyperreactio luteinalis with both
markedly elevated human chorionic gonadotropin levels and an imbalance of
angiogenic factors subsequently developed severe early-onset preeclampsia. Fertil
Steril 2009;92:393, e391–393.
Maymon E, Romero R, Pacora P, Gomez R, Athayde N, Edwin S, Yoon BH. Human
neutrophil collagenase (matrix metalloproteinase 8) in parturition, premature
rupture of the membranes, and intrauterine infection. Am J Obstet Gynecol 2000;
183:94–99.
McGregor JA, Leff M, Orleans M, Baron A. Fetal gender differences in preterm birth:
ﬁndings in a North American cohort. Am J Perinatol 1992;9:43–48.
Mecenas CA, Giussani DA, Owiny JR, Jenkins SL, Wu WX, Honnebier BO,
Lockwood CJ, Kong L, Guller S, Nathanielsz PW. Production of premature
delivery in pregnant rhesus monkeys by androstenedione infusion. Nat Med 1996;
2:443–448.
Meldrum E, Parker PJ, Carozzi A. The PtdIns-PLC superfamily and signal transduction.
Biochim Biophys Acta 1991;1092:49–71.
Mendel CM. The free hormone hypothesis: a physiologically based mathematical
model. Endocr Rev 1989;10:232–274.
Milewich L,Gomez-SanchezC,Madden JD, BradﬁeldDJ, Parker PM, Smith SL,Carr BR,
EdmanCD,MacDonald PC. Dehydroisoandrosterone sulfate in peripheral blood of
premenopausal, pregnant and postmenopausal women and men. J Steroid Biochem
1978;9:1159–1164.
Milewich L, MacDonald PC, Guerami A, Midgett WT, Lassiter WL, Carr BR. Human
fetal liver estrogen 16 alpha-hydroxylase: precursor speciﬁcity, kinetic parameters,
and in vitro regulation. J Clin Endocrinol Metab 1986;63:180–191.
Mitchell FL, ShackletonCH.The investigationof steroidmetabolism in early infancy.Adv
Clin Chem 1969;12:141–215.
Mizuno M, Lobotsky J, Lloyd CW, Kobayashi T, Murasawa Y. Plasma androstenedione
and testerone during pregnancy and in the newborn. J Clin Endocrinol Metab 1968;
28:1133–1142.
Mochizuki M, Maruo T. Effect of dehydroepiandrosterone sulfate on uterine cervical
ripening in late pregnancy. Acta Physiol Hung 1985;65:267–274.
Mochizuki M, Honda T, Deguchi M, Morikawa H, Tojo S. A study on the effect of
dehydroepiandrosterone sulfate on so-called cervical ripening. Acta Obstet Gynecol
Scand 1978a;57:397–401.
Mochizuki M, Honda T, Tojo S. Collagenolytic activity and steroid levels after
administration of dehydroepiandrosterone sulfate. Int J Gynaecol Obstet 1978b;
16:248–253.
Montano LM,Calixto E, FigueroaA, Flores-Soto E, Carbajal V, PerusquiaM. Relaxation
of androgens on rat thoracic aorta: testosterone concentration dependent agonist/
antagonist L-type Ca2+ channel activity, and 5beta-dihydrotestosterone restricted
to L-type Ca2+ channel blockade. Endocrinology 2008;149:2517–2526.
Morisset AS, Dube MC, Drolet R, Pelletier M, Labrie F, Luu-The V, Tremblay Y,
Robitaille J, John Weisnagel S, Tchernof A. Androgens in the maternal and fetal
circulation: association with insulin resistance. J Matern Fetal Neonatal Med 2013;
26:513–519.
Murphy JG, Khalil RA. Decreased [Ca(2+)](i) during inhibition of coronary smooth
muscle contraction by 17beta-estradiol, progesterone, and testosterone.
J Pharmacol Exp Ther 1999;291:44–52.
Nakajima A. Action potential of human myometrial ﬁbers. Am J Obstet Gynecol 1971;
111:266–269.
NathanielszPW, Jenkins SL,Tame JD,Winter JA,Guller S,GiussaniDA.Local paracrine
effects of estradiol are central to parturition in the rhesus monkey. Nat Med 1998;
4:456–459.
Nishinaka K, Fukuda Y. Changes in extracellular matrix materials in the uterine
myometrium of rats during pregnancy and postparturition. Acta Pathol Jpn 1991;
41:122–132.
Noble K,MatthewA, Burdyga T,Wray S. A reviewof recent insights into the role of the
sarcoplasmic reticulum and Ca entry in uterine smooth muscle. Eur J Obstet Gynecol
Reprod Biol 2009;144(Suppl. 1):S11–S19.
Norman JE. Preterm labour.Cervical function andprematurity.Best Pract ResClinObstet
Gynaecol 2007;21:791–806.
Norman M, Ekman G, Malmstrom A. Changed proteoglycan metabolism in human
cervix immediately after spontaneous vaginal delivery. Obstet Gynecol 1993;
81:217–223.
Norman JE, Bollapragada S, Yuan M, Nelson SM. Inﬂammatory pathways in the
mechanism of parturition. BMC Pregnancy Childbirth 2007;7(Suppl. 1):S7.
Novy MJ, Walsh SW. Dexamethasone and estradiol treatment in pregnant rhesus
macaques: effects on gestational length, maternal plasma hormones, and fetal
growth. Am J Obstet Gynecol 1983;145:920–931.
O’BrienM,O’ShaughnessyD,Ahamide E,Morrison JJ, Smith TJ.Differential expression
of the metalloproteinase MMP3 and the alpha5 integrin subunit in human
myometrium at labour.Mol Hum Reprod 2007;13:655–661.
OkonMA, Laird SM,TuckermanEM, Li TC. Serumandrogen levels inwomenwhohave
recurrent miscarriages and their correlation with markers of endometrial function.
Fertil Steril 1998;69:682–690.
O’Leary P, Boyne P, Flett P, Beilby J, James I. Longitudinal assessment of changes in
reproductive hormones during normal pregnancy. Clin Chem 1991;37:667–672.
Ortega A, Mas-Oliva J. Cholesterol effect on enzyme activity of the sarcolemmal
(Ca2+ + Mg2+)-ATPase from cardiac muscle. Biochim Biophys Acta 1984;
773:231–236.
Pasanen M, Pelkonen O. The expression and environmental regulation of P450
enzymes in human placenta. Crit Rev Toxicol 1994;24:211–229.
Penning TM. New frontiers in androgen biosynthesis and metabolism. Curr Opin
Endocrinol Diabetes Obes 2010;17:233–239.
Pereira de Jesus-Tran K, Cote PL, Cantin L, Blanchet J, Labrie F, Breton R. Comparison
of crystal structures of human androgen receptor ligand-binding domain complexed
with various agonists revealsmolecular determinants responsible for binding afﬁnity.
Protein Sci 2006;15:987–999.
Perusquia MC, G. Inhibitory effect of androgens and progestins on the contraction
induced by oxytocin in the rat myometrium.Med Sci Res 1991;19:177–179.
Perusquia M, Garcia-Yanez E, Ibanez R, Kubli-Garﬁas C. Non-genomic mechanism of
action of delta-4 and 5-reduced androgens and progestins on the contractility of
the isolated rat myometrium. Life Sci 1990;47:1547–1553.
Perusquia M, Campos G, Corona JL, Kubli-Garﬁas C. Antagonism by 5-reduced
steroids of the tonic and phasic contractions induced by serotonin in the isolated
rat uterus. Proc West Pharmacol Soc 1991a;34:395–398.
Perusquia M, Corona JL, Kubli-Garﬁas C. Inhibitory effect of 5-reduced androgens and
progestins on the uterine contraction induced by acetylcholine. ProcWest Pharmacol
Soc 1991b;34:89–92.
PerusquiaM,Navarrete E, Jasso-Kamel J,Montano LM.Androgens induce relaxation of
contractile activity in pregnant humanmyometrium at term: a nongenomic action on
L-type calcium channels. Biol Reprod 2005;73:214–221.
PhelanN, ConwayGS. Management of ovarian disease in pregnancy. Best Pract Res Clin
Endocrinol Metab 2011;25:985–992.
Piltonen T, Koivunen R,Morin-Papunen L, RuokonenA,Huhtaniemi IT, Tapanainen JS.
Ovarian and adrenal steroid production: regulatory role of LH/HCG. Hum Reprod
2002;17:620–624.
Pion R, Jaffe R, Eriksson G,Wiqvist N, Diczfalusy E. Studies on the metabolism of c-21
steroids in the human foeto-placental unit. I. Formation of a beta-unsaturated
3-ketones in midterm placentas perfused in situ with pregnenolone and
17-alpha-hydroxypregnenolone. Acta Endocrinol (Copenh) 1965;48:234–248.
Pluciennik F, Verrecchia F, Bastide B, Herve JC, Joffre M, Deleze J. Reversible
interruption of gap junctional communication by testosterone propionate in
cultured Sertoli cells and cardiac myocytes. J Membr Biol 1996;149:169–177.
Pressman EK, Tucker JA Jr, Anderson NC Jr, Young RC. Morphologic and
electrophysiologic characterization of isolated pregnant human myometrial cells.
Am J Obstet Gynecol 1988;159:1273–1279.
Pulkkinen MO, Nyman S, Hamalainen MM, Mattinen J. Proton NMR spectroscopy of
the phospholipids in human uterine smooth muscle and placenta. Gynecol Obstet
Invest 1998;46:220–224.
Purohit A, Foster PA. Steroid sulfatase inhibitors for estrogen- and
androgen-dependent cancers. J Endocrinol 2012;212:99–110.
Rao PM, Kelly DM, Jones TH. Testosterone and insulin resistance in the metabolic
syndrome and T2DM in men. Nat Rev Endocrinol 2013;9:479–493.
Read CP, Word RA, Ruscheinsky MA, Timmons BC, Mahendroo MS. Cervical
remodeling during pregnancy and parturition: molecular characterization of the
softening phase in mice. Reproduction 2007;134:327–340.
16 Makieva et al.
 at Edinburgh U
niversity on M
ay 19, 2014
http://hum
upd.oxfordjournals.org/
D
ow
nloaded from
 
Rehman KS, Yin S, Mayhew BA,Word RA, RaineyWE. Humanmyometrial adaptation
to pregnancy: cDNA microarray gene expression proﬁling of myometrium from
non-pregnant and pregnant women.Mol Hum Reprod 2003;9:681–700.
Richardson MC, Masson GM. Stimulation by human chorionic gonadotrophin of
oestradiol production by dispersed cells from human corpus luteum: comparison
with progesterone production; utilization of exogenous testosterone. J Endocrinol
1981;91:197–203.
Rivarola MA, Forest MG, Migeon CJ. Testosterone, androstenedione and
dehydroepiandrosterone in plasma during pregnancy and at delivery:
concentration and protein binding. J Clin Endocrinol Metab 1968;28:34–40.
Rivas A, Fisher JS, McKinnell C, Atanassova N, Sharpe RM. Induction of reproductive
tract developmental abnormalities in the male rat by lowering androgen
production or action in combination with a low dose of diethylstilbestrol:
evidence for importance of the androgen-estrogen balance. Endocrinology 2002;
143:4797–4808.
Robinson JD, Judd HL, Young PE, Jones OW, Yen SS. Amniotic ﬂuid androgens and
estrogens in midgestation. J Clin Endocrinol Metab 1977;45:755–761.
Robson . Reactions of the uterine muscle and endometrium of rabbit to testosterone.
Quart J Exp Physiol 1937;35:355–363.
Rodeck CH, Gill D, Rosenberg DA, Collins WP. Testosterone levels in midtrimester
maternal and fetal plasma and amniotic ﬂuid. Prenat Diagn 1985;5:175–181.
Roh CR, Oh WJ, Yoon BK, Lee JH. Up-regulation of matrix metalloproteinase-9 in
human myometrium during labour: a cytokine-mediated process in uterine
smooth muscle cells.Mol Hum Reprod 2000;6:96–102.
Romero R, Espinoza J, Goncalves LF, Kusanovic JP, Friel L, Hassan S. The role of
inﬂammation and infection in preterm birth. Semin Reprod Med 2007;25:21–39.
Rosano GM, Leonardo F, Pagnotta P, Pelliccia F, Panina G, Cerquetani E, della
Monica PL, Bonﬁgli B, Volpe M, Chierchia SL. Acute anti-ischemic effect of
testosterone in men with coronary artery disease. Circulation 1999;99:1666–1670.
Rosmond R. Androgen excess in women—a health hazard? Med Hypotheses 2006;
67:229–234.
Rothman MS, Carlson NE, Xu M, Wang C, Swerdloff R, Lee P, Goh VH, Ridgway EC,
Wierman ME. Reexamination of testosterone, dihydrotestosterone, estradiol and
estrone levels across the menstrual cycle and in postmenopausal women
measured by liquid chromatography-tandem mass spectrometry. Steroids 2011;
76:177–182.
Saez JM, Forest MG, Morera AM, Bertrand J. Metabolic clearance rate and blood
production rate of testosterone and dihydrotestosterone in normal subjects,
during pregnancy, and in hyperthyroidism. J Clin Invest 1972;51:1226–1234.
Sakyo K, Ito A, Mori Y. Effects of dehydroepiandrosterone sulphate on the production
of collagenase and gelatinolytic metalloproteinase by rabbit uterine cervical cells in
primary cultures. J Pharmacobiodyn 1986;9:276–286.
Sakyo K, Ito A, Mori Y. Dehydroepiandrosterone sulfate stimulates collagenase
synthesis without affecting the rates of collagen and noncollagen protein syntheses
by rabbit uterine cervical ﬁbroblasts. Biol Reprod 1987;36:277–281.
Sanders SL, Stouffer RL, Brannian JD. Androgen production by monkey luteal cell
subpopulations at different stages of the menstrual cycle. J Clin Endocrinol Metab
1996;81:591–596.
Sasaki K, Nakano R, Kadoya Y, Iwao M, Shima K, Sowa M. Cervical ripening with
dehydroepiandrosterone sulphate. Br J Obstet Gynaecol 1982;89:195–198.
Sathishkumar K, Balakrishnan M, Chinnathambi V, Chauhan M, Hankins GD,
Yallampalli C. Fetal sex-related dysregulation in testosterone production and their
receptor expression in the human placenta with preeclampsia. J Perinatol 2012;
32:328–335.
Schwarzel WC, Kruggel WG, Brodie HJ. Studies on the mechanism of estrogen
biosynthesis. 8. The development of inhibitors of the enzyme system in human
placenta. Endocrinology 1973;92:866–880.
Scott HM, Hutchison GR, Mahood IK, Hallmark N, Welsh M, De Gendt K,
Verhoeven G, O’Shaughnessy P, Sharpe RM. Role of androgens in fetal testis
development and dysgenesis. Endocrinology 2007;148:2027–2036.
Scott HM, Mason JI, Sharpe RM. Steroidogenesis in the fetal testis and its susceptibility
to disruption by exogenous compounds. Endocr Rev 2009;30:883–925.
SenA,Hammes SR.Granulosa cell-speciﬁc androgen receptors arecritical regulators of
ovarian development and function.Mol Endocrinol 2010;24:1393–1403.
Sharifzadeh F, Kashanian M, Fatemi F. A comparison of serum androgens in
pre-eclamptic and normotensive pregnant women during the third trimester of
pregnancy. Gynecol Endocrinol 2012;28:834–836.
Shmigol A, Eisner DA, Wray S. Carboxyeosin decreases the rate of decay of the
[Ca2+]i transient in uterine smooth muscle cells isolated from pregnant rats.
Pﬂugers Arch 1998;437:158–160.
Shmygol A, Noble K, Wray S. Depletion of membrane cholesterol eliminates the
Ca2+-activated component of outward potassium current and decreases
membrane capacitance in rat uterine myocytes. J Physiol 2007;581:445–456.
Shozu M, Akasofu K, Harada T, Kubota Y. A new cause of female
pseudohermaphroditism: placental aromatase deﬁciency. J Clin Endocrinol Metab
1991;72:560–566.
ShynlovaO,Mitchell JA, TsampalierosA, Langille BL, Lye SJ. Progesterone and gravidity
differentially regulate expression of extracellularmatrix components in the pregnant
rat myometrium. Biol Reprod 2004;70:986–992.
Shynlova O, Tsui P, Dorogin A, Langille BL, Lye SJ. Insulin-like growth factors and their
binding proteins deﬁne speciﬁc phases of myometrial differentiation during
pregnancy in the rat. Biol Reprod 2007;76:571–578.
ShynlovaO,Tsui P, Jaffer S, Lye SJ. Integrationof endocrine andmechanical signals in the
regulation of myometrial functions during pregnancy and labour. Eur J Obstet Gynecol
Reprod Biol 2009;144(Suppl. 1):S2–10.
Siiteri PK, MacDonald PC. Placental estrogen biosynthesis during human pregnancy.
J Clin Endocrinol Metab 1966;26:751–761.
Siiteri PK, SimbergNH. Changing concepts of active androgens in blood. Clin Endocrinol
Metab 1986;15:247–258.
Simon C, Einspanier A. The hormonal induction of cervical remodeling in the common
marmoset monkey (Callithrix jacchus). Reproduction 2009;137:517–525.
Simons K, Vaz WL. Model systems, lipid rafts, and cell membranes. Annu Rev Biophys
Biomol Struct 2004;33:269–295.
Simpson ER, Mahendroo MS, Means GD, Kilgore MW, Hinshelwood MM,
Graham-Lorence S, Amarneh B, Ito Y, Fisher CR, Michael MD et al. Aromatase
cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr Rev
1994;15:342–355.
Simsek Y, Celen S, UstunY,DanismanN, BayramogluH. Severe preeclampsia and fetal
virilization in a spontaneous singleton pregnancy complicated by hyperreactio
luteinalis. Eur Rev Med Pharmacol Sci 2012;16:118–121.
Sir-Petermann T, Maliqueo M, Angel B, Lara HE, Perez-Bravo F, Recabarren SE.
Maternal serum androgens in pregnant women with polycystic ovarian syndrome:
possible implications in prenatal androgenization.HumReprod2002;17:2573–2579.
Sir-Petermann T, Hitchsfeld C, Maliqueo M, Codner E, Echiburu B, Gazitua R,
Recabarren S, Cassorla F. Birth weight in offspring of mothers with polycystic
ovarian syndrome. Hum Reprod 2005;20:2122–2126.
Slater DM, Dennes WJ, Campa JS, Poston L, Bennett PR. Expression of
cyclo-oxygenase types-1 and -2 in human myometrium throughout pregnancy.
Mol Hum Reprod 1999;5:880–884.
SlaydenOD,NayakNR,BurtonKA,ChwaliszK,Cameron ST,CritchleyHO,BairdDT,
Brenner RM. Progesterone antagonists increase androgen receptor expression in
the rhesus macaque and human endometrium. J Clin Endocrinol Metab 2001;
86:2668–2679.
Slomczynska M, Duda M, Burek M, Knapczyk K, Czaplicki D, Koziorowski M.
Distribution of androgen receptor in the porcine uterus throughout pregnancy.
Reprod Domest Anim 2008;43:35–41.
Smith R. Parturition. N Engl J Med 2007;356:271–283.
Smith RD, Babiychuk EB,NobleK,DraegerA,WrayS. Increased cholesterol decreases
uterine activity: functional effects of cholesterol alteration in pregnant rat
myometrium. Am J Physiol Cell Physiol 2005;288:C982–C988.
Smith R, Paul J, Maiti K, Tolosa J, Madsen G. Recent advances in understanding the
endocrinology of human birth. Trends Endocrinol Metab 2012;23:516–523.
Sooranna SR, Lee Y, Kim LU, Mohan AR, Bennett PR, Johnson MR. Mechanical stretch
activates type 2 cyclooxygenase via activator protein-1 transcription factor in human
myometrial cells.Mol Hum Reprod 2004;10:109–113.
SpareyC, Robson SC, Bailey J, Lyall F, Europe-FinnerGN. The differential expression of
myometrial connexin-43, cyclooxygenase-1 and -2, and Gs alpha proteins in the
upper and lower segments of the human uterus during pregnancy and labor. J Clin
Endocrinol Metab 1999;84:1705–1710.
Stocco C, Telleria C, Gibori G. The molecular control of corpus luteum formation,
function, and regression. Endocr Rev 2007;28:117–149.
Stouffer RL,NixonWE,Gulyas BJ, HodgenGD.Gonadotropin-sensitive progesterone
production by rhesus monkey luteal cells in vitro: a function of age of the corpus
luteum during the menstrual cycle. Endocrinology 1977;100:506–512.
Androgens in pregnancy: roles in parturition 17
 at Edinburgh U
niversity on M
ay 19, 2014
http://hum
upd.oxfordjournals.org/
D
ow
nloaded from
 
Strauss JF 3rd, Martinez F, Kiriakidou M. Placental steroid hormone synthesis: unique
features and unanswered questions. Biol Reprod 1996;54:303–311.
Tagawa N, Hidaka Y, Takano T, Shimaoka Y, Kobayashi Y, Amino N. Serum
concentrations of dehydroepiandrosterone and dehydroepiandrosterone sulfate
and their relation to cytokine production during and after normal pregnancy. Clin
Chim Acta 2004;340:187–193.
Takahashi K, Ikeno N, Hoshiai H, Suzuki M. The effect of dehydroepiandrosterone
sulfate on serum steroid concentration in singleton and twin pregnancies and its
effect on cervical canal-ripening in singleton pregnancies. Tohoku J Exp Med 1984;
142:289–298.
Tep-areenan P, Kendall DA, Randall MD. Testosterone-induced vasorelaxation in the
rat mesenteric arterial bed is mediated predominantly via potassium channels. Br J
Pharmacol 2002;135:735–740.
Terzidou V, Sooranna SR, Kim LU, Thornton S, Bennett PR, Johnson MR. Mechanical
stretch up-regulates the human oxytocin receptor in primary human uterine
myocytes. J Clin Endocrinol Metab 2005;90:237–246.
Thiery M, De Gezelle H, Van Kets H, Voorhoof L, Verheugen C, Smis B, Gerris J,
Derom R, Martens G. The effect of locally administered estrogens on the human
cervix. Z Geburtshilfe Perinatol 1979;183:448–452.
Thomas P, DressingG, Pang Y, Berg H, TubbsC, Benninghoff A, Doughty K. Progestin,
estrogen and androgen G-protein coupled receptors in ﬁsh gonads. Steroids 2006;
71:310–316.
Thorneloe KS, Nelson MT. Ion channels in smooth muscle: regulators of intracellular
calcium and contractility. Can J Physiol Pharmacol 2005;83:215–242.
Tica AA, Dun EC, Tica OS, Gao X, Arterburn JB, Brailoiu GC, Oprea TI, Brailoiu E. G
protein-coupled estrogen receptor 1-mediated effects in the rat myometrium. Am J
Physiol Cell Physiol 2011;301:C1262–C1269.
Tomiyasu BA, Chen CJ, Marshall JM. Comparison of the activity of circular and
longitudinal myometrium from pregnant rats: co-ordination between muscle
layers. Clin Exp Pharmacol Physiol 1988;15:647–656.
Traish AM, Kang HP, Saad F, Guay AT. Dehydroepiandrosterone (DHEA)—a
precursor steroid or an active hormone in human physiology. J Sex Med 2011;
8:2960–2982; quiz 2983.
Tsai ML, Cesen-Cummings K, Webb RC, Loch-Caruso R. Acute inhibition of
spontaneous uterine contractions by an estrogenic polychlorinated biphenyl is
associated with disruption of gap junctional communication. Toxicol Appl
Pharmacol 1998;152:18–29.
Umezaki H, Hess DL, Valenzuela GJ, Ducsay CA. Fetectomy alters maternal
pituitary-adrenal function in pregnant rhesus macaques. Biol Reprod 2001;
65:1616–1621.
Van Bommel T, Marsen T, Bojar H. Effects of high-dose medroxyprogesterone acetate
and various other steroid hormones on plasmamembrane lipidmobility in CAMA-1
mammary cancer cells. Anticancer Res 1987;7:1217–1223.
van der Kwast TH, Dommerholt HB, van Vroonhoven CC, Chadha S. Androgen
receptor expression in the cervix of androgen-treated female-to-male
transsexuals: association with morphology and chain-speciﬁc keratin expression.
Int J Gynecol Pathol 1994;13:133–138.
Van Holsbeke C, Amant F, Veldman J, De Boodt A, Moerman P, Timmerman D.
Hyperreactio luteinalis in a spontaneously conceived singleton pregnancy.
Ultrasound Obstet Gynecol 2009;33:371–373.
van Meer G. Lipid trafﬁc in animal cells. Annu Rev Cell Biol 1989;5:247–275.
Vejrazkova D, Vcelak J, Vankova M, Lukasova P, Bradnova O, Halkova T, Kancheva R,
Bendlova B. Steroids and insulin resistance in pregnancy. J Steroid Biochem Mol Biol
2014;139:122–129.
Veleminsky M Jr. Hyperreactio luteinalis in spontaneous singleton pregnancy. Neuro
Endocrinol Lett 2010;31:304–305.
Verbist J, Gadella TW Jr, Raeymaekers L, Wuytack F, Wirtz KW, Casteels R.
Phosphoinositide-protein interactions of the plasma-membrane Ca2(+)-
transport ATPase as revealed by ﬂuorescence energy transfer. Biochim Biophys
Acta 1991;1063:1–6.
Vermeirsch H, Van den Broeck W, Coryn M, Simoens P. Immunohistochemical
detection of androgen receptors in the canine uterus throughout the estrus cycle.
Theriogenology 2002;57:2203–2216.
Vermeulen A, Ando S. Metabolic clearance rate and interconversion of androgens
and the inﬂuence of the free androgen fraction. J Clin Endocrinol Metab 1979;
48:320–326.
Vladic-Stjernholm Y, Vladic T, Blesson CS, Ekman-Ordeberg G, Sahlin L. Prostaglandin
treatment is associated with a withdrawal of progesterone and androgen at the
receptor level in the uterine cervix. Reprod Biol Endocrinol 2009;7:116.
Walters KA, Allan CM, Handelsman DJ. Androgen actions and the ovary. Biol Reprod
2008;78:380–389.
Webley GE, Hearn JP. Local production of progesterone by the corpus luteum of the
marmoset monkey in response to perfusion with chorionic gonadotrophin and
melatonin in vivo. J Endocrinol 1987;112:449–457.
Welsh M, Saunders PT, Fisken M, Scott HM, Hutchison GR, Smith LB, Sharpe RM.
Identiﬁcation in rats of a programming window for reproductive tract
masculinization, disruption of which leads to hypospadias and cryptorchidism.
J Clin Invest 2008;118:1479–1490.
Wilke TJ, Utley DJ. Total testosterone, free-androgen index, calculated free
testosterone, and free testosterone by analog RIA compared in hirsute women
and in otherwise-normal women with altered binding of sex-hormone-binding
globulin. Clin Chem 1987;33:1372–1375.
Willows RL. Urinary estriol estimations in normal and abnormal pregnancies. Can Med
Assoc J 1966;94:1098–1101.
Wilson CM, McPhaul MJ. A and B forms of the androgen receptor are expressed in a
variety of human tissues.Mol Cell Endocrinol 1996;120:51–57.
Witayavanitkul N, Woranush W, Bupha-Intr T, Wattanapermpool J. Testosterone
regulates cardiac contractile activation by modulating SERCA but not NCX
activity. Am J Physiol Heart Circ Physiol 2013;304:H465–H472.
WordRA, LiXH,HnatM,CarrickK.Dynamicsof cervical remodelingduring pregnancy
and parturition: mechanisms and current concepts. Semin Reprod Med 2007;
25:69–79.
Wray S, Jones K, Kupittayanant S, Li Y, Matthew A, Monir-Bishty E, Noble K, Pierce SJ,
Quenby S, Shmygol AV. Calcium signaling and uterine contractility. J Soc Gynecol
Investig 2003;10:252–264.
Wray S, Burdyga T, Noble K. Calcium signalling in smooth muscle. Cell Calcium 2005;
38:397–407.
Yamamoto M, Feigenbaum SL, Crites Y, Escobar GJ, Yang J, Ferrara A, Lo JC. Risk of
preterm delivery in non-diabetic women with polycystic ovarian syndrome.
J Perinatol 2012;32:770–776.
Yamashita A, Oshima S, Matsuo K, Ito K, Ito A, Mori Y. Pharmacological studies of
intravaginally applied dehydroepiandrosterone sulfate (DHA-S). Nihon Yakurigaku
Zasshi 1991;98:31–39.
YangX,GuoZ, Sun F, LiW,AlfanoA, Shimelis H, ChenM, BrodieAM,ChenH,XiaoZ
et al. Novel membrane-associated androgen receptor splice variant potentiates
proliferative and survival responses in prostate cancer cells. J Biol Chem 2011;
286:36152–36160.
Zeitlin J, Saurel-CubizollesMJ,DeMouzon J, Rivera L, Ancel PY, Blondel B, KaminskiM.
Fetal sex and preterm birth: are males at greater risk? Hum Reprod 2002;
17:2762–2768.
Zhang J, Bricker L,Wray S,Quenby S. Poor uterine contractility in obesewomen. BJOG
2007;114:343–348.
18 Makieva et al.
 at Edinburgh U
niversity on M
ay 19, 2014
http://hum
upd.oxfordjournals.org/
D
ow
nloaded from
 
